www.oojbs.com_申慱娱乐试玩《Doctor-X》将出续集

社友网

2019-10-19 04:50:59

字体:标准

  AfyaSerengetiProjectFormorethan15years,haspartneredwiththe(Afyameans"health"inSwahili)intheSerengetiregionofTanzaniaineasternAfrica.Wehelpprovideaccesstopreventivecare,includingrabiesvaccinationsforlocaldogs.Todate,wehavedonatedtwomillionrabiesvaccinestosupportprogramsinIndia,Malawi,SriLanka,TanzaniaandUganda.Wealsoprovidetoolssuchasall-terrainvehiclesandtentstohelpmakesuretheprojectisabletoreachthemostremotecornersoftheregion.Rabiesinhumansanddomesticanimalshasnowbeenvirtuallyeliminatedfromthisareaandhumanhospitalizationsduetorabiddogbiteshavedecreased92percent.Antibioticshaverevolutionizedmedicineinmanyrespects,andcountlessliveshavebeensaved;theirdiscoverywasaturningpointinhumanhistory.Foralmostacentury,bacteria-fightingdrugsknownasantibioticshavehelpedtomanagemanyoftheharmfulbacteriathatcanmakeussick.Butinrecentdecades,theyhavebecomelesseffectiveagainstsometypesofbacteria.Currently,certainbacteriaarenowunbeatablewithtoday’smedicines.Unfortunately,newdrug-resistant“superbugs”haveemerged,whicharestrainsofbacteriathatareresistanttoseveraltypesofantibiotics.Infact,theWorldHealthOrganizationhasclassifiedthisas“aseriousthreat[that]isnolongerapredictionforthefuture,itishappeningrightnowineveryregionoftheworldandhasthepotentialtoaffectanyone,ofanyage,inanycountry.”“EventhoughDr.Alzheimercharacterizedthediseasein1906,itwasn’tuntilthelastfewdecadesthatthediseasebecamerecognizedasarealillnessseparatefromnormalagingandotherformsofdementia,”saidDarryleSchoepp,Ph.D.,vicepresidentandtherapeuticareahead,Neuroscience,MSD.“Nowpeoplearelivinglonger,andwecanseehowthediseaseworks,”saidDavidMichelson,M.D.,vicepresident,ClinicalNeuroscienceResearch,MSD.“Scienceisataplacewherenotonlydoweunderstandmoreaboutit,butweareexploringwaystodosomethingaboutit.”“Newtechnologiesareallowingtheidentificationofearlydiseasesignswhichwehopewillallowustointervenepromptlyinordertosloworhaltprogression.That’stheholygrail.Whatyouwanttodoistohavesomethingthatworksandtobeabletouseitbeforethediseaserobspeopleofwhotheyreallyare,”saidDr.Michelson.

  Intheearly1990s,HedyTepplerwastreatingAIDSpatientswithHIV/AIDSatahospitalinPhiladelphia.ShewasalsoservingasaclinicaltrialinvestigatorforPhase1and2MSDstudiesofanewclassofanti-HIVdrugsdesignedtoblocktheHIVproteaseenzymeandthuspreventHIVreplication."Theearlyresultswereexciting.Inashorttime,manypatientsrespondedtotheinvestigationaltreatment,"saysHedy.HerpositiveexperienceduringtheseandsubsequentclinicaltrialswaslargelywhyshejoinedMSDin1996."Iwantedtobemoreinvolvedindrugdevelopmentandclinicaltrialdesign,andMSDwasdoingsomegroundbreakingworkinHIV,"saysHedy,whonowservesasexecutivedirector,ClinicalResearch,InfectiousDiseases,atMSDResearchLaboratories.TheyearbeforeHedyarrived,anotherprominentHIVresearcherandthoughtleaderwaskeepingaclosewatchonMSD'swork.Bach-YenNguyen,nowretired-executivedirector,sectionhead,HCVandHIV,decidedtoleavetheNationalInstitutesofHealthtoworkonMSD'sHIVresearchdevelopmentteam.Bach-YenhadspentyearstreatingAIDSpatientsandworkinginHIVresearchandsawgreatpotentialinMSD'swork."WewerefacedwithanopportunitytohelppatientsinfectedwithHIV."ForBach-Yen,whoalsomadevitalcontributionstothedevelopmentofanotheroneofMSD'smedicinesforthetreatmentofHIV,thedrug'sapprovalcontinuestobehermostmemorablemomentatMSD."Weworkedlonghours.ThereweretimeswhenIcouldn'tattendschooleventswithmyson.WhenpeopleaskedhimwhereIwas,hewouldsay,'MomisbusyhelpingpeoplewithAIDS.'Hewasonly12,butheunderstoodtheimportanceofthework."Withinafewyears,theteamachievedadditionalsuccess:In2011,theFDAapprovedachewabletabletformofthisfirstagentinanewclassofanti-HIVagentsforchildren2yearsandolder,andin2013,approvedgranulesfororalsuspensionforinfants4weeksandolder."Ourpediatricsprogramhasbeenextremelysatisfyingasthereisatremendousneedfornewanti-HIVagentsthatcanbeusedacrosstheentirepediatricagerange,"saysHedy,wholeadstheIsentresspediatricdevelopmentprogram.Intheearly1990s,HedyTepplerwastreatingAIDSpatientswithHIV/AIDSatahospitalinPhiladelphia.ShewasalsoservingasaclinicaltrialinvestigatorforPhase1and2MSDstudiesofanewclassofanti-HIVdrugsdesignedtoblocktheHIVproteaseenzymeandthuspreventHIVreplication."Theearlyresultswereexciting.Inashorttime,manypatientsrespondedtotheinvestigationaltreatment,"saysHedy.HerpositiveexperienceduringtheseandsubsequentclinicaltrialswaslargelywhyshejoinedMSDin1996."Iwantedtobemoreinvolvedindrugdevelopmentandclinicaltrialdesign,andMSDwasdoingsomegroundbreakingworkinHIV,"saysHedy,whonowservesasexecutivedirector,ClinicalResearch,InfectiousDiseases,atMSDResearchLaboratories.TheyearbeforeHedyarrived,anotherprominentHIVresearcherandthoughtleaderwaskeepingaclosewatchonMSD'swork.Bach-YenNguyen,nowretired-executivedirector,sectionhead,HCVandHIV,decidedtoleavetheNationalInstitutesofHealthtoworkonMSD'sHIVresearchdevelopmentteam.Bach-YenhadspentyearstreatingAIDSpatientsandworkinginHIVresearchandsawgreatpotentialinMSD'swork."WewerefacedwithanopportunitytohelppatientsinfectedwithHIV."ForBach-Yen,whoalsomadevitalcontributionstothedevelopmentofanotheroneofMSD'smedicinesforthetreatmentofHIV,thedrug'sapprovalcontinuestobehermostmemorablemomentatMSD."Weworkedlonghours.ThereweretimeswhenIcouldn'tattendschooleventswithmyson.WhenpeopleaskedhimwhereIwas,hewouldsay,'MomisbusyhelpingpeoplewithAIDS.'Hewasonly12,butheunderstoodtheimportanceofthework."Withinafewyears,theteamachievedadditionalsuccess:In2011,theFDAapprovedachewabletabletformofthisfirstagentinanewclassofanti-HIVagentsforchildren2yearsandolder,andin2013,approvedgranulesfororalsuspensionforinfants4weeksandolder."Ourpediatricsprogramhasbeenextremelysatisfyingasthereisatremendousneedfornewanti-HIVagentsthatcanbeusedacrosstheentirepediatricagerange,"saysHedy,wholeadstheIsentresspediatricdevelopmentprogram.Overthelast20years,MSD’svaccineoperationsinEuropehavebeenpartofajointventurebetweenthecompaniesSanofiandMSD,calledSanofiPasteurMSD(SPMSD).SanofiPasteurMSD—ownedona50/50basisbySanofiPasteurandMSD—wascreatedin1994todevelopandcommercializevaccinesoriginatingfrombothcompanies’pipelinestoimproveandpromotepublichealthin19Europeancountries.Aftercarefullyconsideringourindividualstrategicpriorities,alongsidetheeconomicandregulatoryenvironmentsforvaccineoperationsintheEuropeanUnion,bothcompaniesmutuallyagreedinMarchof2016thatitisinourbestintereststomanageourvaccineproductportfoliosindependently.SanofiPasteurandMSDbelievethatreintegratingtheirrespectivevaccineportfoliosintotheircompanies’operationswillbetterpositionthemtodrivegrowth,executemoreefficiently,optimizevaccinecoverageandbringnewvaccinestomarketmorequickly.Eachcompanywillnowbeabletodefineitsownvaccinesstrategytobenefitpublichealthandcreatevalueforpatients,healthcareprofessionalsandpayers.Throughouttheyear,SPMSDanditsshareholdershavebeenfocusedonasmoothandorderlytransitionwhileachievingtheirpublichealthcaregoalsandupholdingtheircommitmentstotheiremployees,customersandbusinesspartners.Followingthistransitionalperiod,bothcompanieshaveconfirmedthatDec.31,2016willbetheofficialclosingdateoftheendoftheirvaccinesjointventureSanofiPasteurMSD(SPMSD),followingclearancesrecentlygrantedbytheEuropeanCommission.

  “EventhoughDr.Alzheimercharacterizedthediseasein1906,itwasn’tuntilthelastfewdecadesthatthediseasebecamerecognizedasarealillnessseparatefromnormalagingandotherformsofdementia,”saidDarryleSchoepp,Ph.D.,vicepresidentandtherapeuticareahead,Neuroscience,MSD.“Nowpeoplearelivinglonger,andwecanseehowthediseaseworks,”saidDavidMichelson,M.D.,vicepresident,ClinicalNeuroscienceResearch,MSD.“Scienceisataplacewherenotonlydoweunderstandmoreaboutit,butweareexploringwaystodosomethingaboutit.”“Newtechnologiesareallowingtheidentificationofearlydiseasesignswhichwehopewillallowustointervenepromptlyinordertosloworhaltprogression.That’stheholygrail.Whatyouwanttodoistohavesomethingthatworksandtobeabletouseitbeforethediseaserobspeopleofwhotheyreallyare,”saidDr.Michelson.TheImpactofStigmatizationThesenorms,behaviors,andbeliefssurroundinghepatitisCinfectioncanleadtoalienationfromfamilyandfriends,aswellastodiscrimination(perceivedorreal)inhealthservicesandworkplaces.Indeed,manychronichepatitisCpatientsreportfeelingsofstigmatizationandsocialisolationfromtheirfriends,family,andcoworkers.WevetalkedtoHCVinfectedgrandmotherswhoseownchildrenwon’tallowthemtoplaywiththeirgrandchildrenbecausethey’reafraidofsomesortoftransmission,reportsMichaelNinburg,executivedirectoroftheHepatitisEducationProject,aSeattle-basedgroupfoundedin1993toprovideeducation,support,andadvocacyforthoselivingwithhepatitis.ArecentlydiagnosedpatientwhoworkswithMichael’sgroupechoedthissentiment.I'msuperoutgoing.ItalkabouteveryfeelingIhavetomyfriends,justaboutanybody,andmydiagnosiswassomethingIcouldnottalkabout,hesaid.IknewthatIhadtodosomethingaboutit,butIwasashamed.Overthepast125years,we’veseentheworldchangethroughthepowerofmedicineandinvention.Whileeachpivotalmilestonehasbeenunique,onethingtheyhaveincommonisthatwehaven’tdoneitalone.AtMSD,wehavealwaysbelievedthatgreatmedicalbreakthroughsrelyonteamwork–fromwithinandoutsideofMSD–andourhistoryhasprovenit.Weareproudtohaveworkedinpartnershipwithcompanies,academics,governments,patientorganizations,healthcareprofessionals,nongovernmentalorganizations(NGOs),multilateralorganizationsandothersintheprivatesector--tohelpimprovelivesaroundtheworldandcontinuetosolvesomeoftheworld’smostseriousillnesses.

  Overthelast20years,MSD’svaccineoperationsinEuropehavebeenpartofajointventurebetweenthecompaniesSanofiandMSD,calledSanofiPasteurMSD(SPMSD).SanofiPasteurMSD—ownedona50/50basisbySanofiPasteurandMSD—wascreatedin1994todevelopandcommercializevaccinesoriginatingfrombothcompanies’pipelinestoimproveandpromotepublichealthin19Europeancountries.Aftercarefullyconsideringourindividualstrategicpriorities,alongsidetheeconomicandregulatoryenvironmentsforvaccineoperationsintheEuropeanUnion,bothcompaniesmutuallyagreedinMarchof2016thatitisinourbestintereststomanageourvaccineproductportfoliosindependently.SanofiPasteurandMSDbelievethatreintegratingtheirrespectivevaccineportfoliosintotheircompanies’operationswillbetterpositionthemtodrivegrowth,executemoreefficiently,optimizevaccinecoverageandbringnewvaccinestomarketmorequickly.Eachcompanywillnowbeabletodefineitsownvaccinesstrategytobenefitpublichealthandcreatevalueforpatients,healthcareprofessionalsandpayers.Throughouttheyear,SPMSDanditsshareholdershavebeenfocusedonasmoothandorderlytransitionwhileachievingtheirpublichealthcaregoalsandupholdingtheircommitmentstotheiremployees,customersandbusinesspartners.Followingthistransitionalperiod,bothcompanieshaveconfirmedthatDec.31,2016willbetheofficialclosingdateoftheendoftheirvaccinesjointventureSanofiPasteurMSD(SPMSD),followingclearancesrecentlygrantedbytheEuropeanCommission.In1987,MSD’sthenCEODr.P.RoyVagelosannounced,inanunprecedentedactofglobalhealthcareleadership,thatMSDwoulddonateivermectin–asmuchasneededforaslongasneeded–withthegoaltohelpeliminateriverblindness.MSDrecognizedinordertoreachthisgoal,manyorganizationswithuniqueskillswouldneedtoworktogetherasateam.Asaresult,MSDcreatedtheMectizanDonationProgram(MDP).OperatingfromtheAtlanta-basedTaskForceforGlobalHealth,theMDPcoordinatesactivitiesbetweenMSD,WHO,theWorldBankandarangeofpublicandprivatestakeholders.In1998,MSDexpandeditscommitmentfromtheMectizanDonationProgramtoincludedonatingivermectinforanotherdisease,lymphaticfilariasis(LF),alsoknownaselephantiasis,inAfricancountriesandYemenwhereitco-existswithriverblindness.ForLF,ivermectinisadministeredwithalbendazole,adrugdonatedbyGSK.TheMSDFellowshipforGlobalHealthisonewayMSDishelpinganswertheglobalhealthneedsoftheunderserved.MSDemployeeswhoparticipateintheprogramarecalledRichardT.ClarkFellows(RTCFellows)inhonorofretiredChairmanandCEORichardT.Clarkandhisphilosophyofpassion,purposeandcommitmenttocorporateresponsibility.Launchedin2012,theprogramoffersMSDemployeesopportunitiestosharetheirskillswithpeoplearoundtheworld.Asmanyas30Fellowsareselectedeachyear;theexpertiseoftheapplicantsismatchedtotheneedsofthepartnerorganizations.Duringthethree-monthassignments,theFellowsareembeddedwithinanon-profitorganizationinthefield.

  AfyaSerengetiProjectFormorethan15years,haspartneredwiththe(Afyameans"health"inSwahili)intheSerengetiregionofTanzaniaineasternAfrica.Wehelpprovideaccesstopreventivecare,includingrabiesvaccinationsforlocaldogs.Todate,wehavedonatedtwomillionrabiesvaccinestosupportprogramsinIndia,Malawi,SriLanka,TanzaniaandUganda.Wealsoprovidetoolssuchasall-terrainvehiclesandtentstohelpmakesuretheprojectisabletoreachthemostremotecornersoftheregion.Rabiesinhumansanddomesticanimalshasnowbeenvirtuallyeliminatedfromthisareaandhumanhospitalizationsduetorabiddogbiteshavedecreased92percent.Ourdiscoveryscientists“strivetomaketheimpossiblepossible,”saysJoeMiletich.Andheshouldknow:AstheseniorvicepresidentofDiscoveryPreclinicalandEarlyDevelopment,heleadsateamofresearcherswhoarechargedwithmakingthings“possiblethatweren’tpossiblebefore.”Hecontinues:“Webelievedrugdiscoveryisfoundationalforustocontinuebringingcriticalmedicinestotheworld.”About14,500peopleareinvolvedinscientificresearchatMSD.OurRDcolleaguesarealltaskedwiththesamemission:tosolvethepuzzlesofhumandiseasebiologyandthentranslatethosefindingsintonewtherapiesforpatients.Theyaredriventopushtheboundariesofscienceandtothentransformtheirdiscoveriesintomeaningfulnewtherapeutics.Overthepast125years,we’veseentheworldchangethroughthepowerofmedicineandinvention.Whileeachpivotalmilestonehasbeenunique,onethingtheyhaveincommonisthatwehaven’tdoneitalone.AtMSD,wehavealwaysbelievedthatgreatmedicalbreakthroughsrelyonteamwork–fromwithinandoutsideofMSD–andourhistoryhasprovenit.Weareproudtohaveworkedinpartnershipwithcompanies,academics,governments,patientorganizations,healthcareprofessionals,nongovernmentalorganizations(NGOs),multilateralorganizationsandothersintheprivatesector--tohelpimprovelivesaroundtheworldandcontinuetosolvesomeoftheworld’smostseriousillnesses.

  Overthelast20years,MSD’svaccineoperationsinEuropehavebeenpartofajointventurebetweenthecompaniesSanofiandMSD,calledSanofiPasteurMSD(SPMSD).SanofiPasteurMSD—ownedona50/50basisbySanofiPasteurandMSD—wascreatedin1994todevelopandcommercializevaccinesoriginatingfrombothcompanies’pipelinestoimproveandpromotepublichealthin19Europeancountries.Aftercarefullyconsideringourindividualstrategicpriorities,alongsidetheeconomicandregulatoryenvironmentsforvaccineoperationsintheEuropeanUnion,bothcompaniesmutuallyagreedinMarchof2016thatitisinourbestintereststomanageourvaccineproductportfoliosindependently.SanofiPasteurandMSDbelievethatreintegratingtheirrespectivevaccineportfoliosintotheircompanies’operationswillbetterpositionthemtodrivegrowth,executemoreefficiently,optimizevaccinecoverageandbringnewvaccinestomarketmorequickly.Eachcompanywillnowbeabletodefineitsownvaccinesstrategytobenefitpublichealthandcreatevalueforpatients,healthcareprofessionalsandpayers.Throughouttheyear,SPMSDanditsshareholdershavebeenfocusedonasmoothandorderlytransitionwhileachievingtheirpublichealthcaregoalsandupholdingtheircommitmentstotheiremployees,customersandbusinesspartners.Followingthistransitionalperiod,bothcompanieshaveconfirmedthatDec.31,2016willbetheofficialclosingdateoftheendoftheirvaccinesjointventureSanofiPasteurMSD(SPMSD),followingclearancesrecentlygrantedbytheEuropeanCommission.Antibioticshaverevolutionizedmedicineinmanyrespects,andcountlessliveshavebeensaved;theirdiscoverywasaturningpointinhumanhistory.Foralmostacentury,bacteria-fightingdrugsknownasantibioticshavehelpedtomanagemanyoftheharmfulbacteriathatcanmakeussick.Butinrecentdecades,theyhavebecomelesseffectiveagainstsometypesofbacteria.Currently,certainbacteriaarenowunbeatablewithtoday’smedicines.Unfortunately,newdrug-resistant“superbugs”haveemerged,whicharestrainsofbacteriathatareresistanttoseveraltypesofantibiotics.Infact,theWorldHealthOrganizationhasclassifiedthisas“aseriousthreat[that]isnolongerapredictionforthefuture,itishappeningrightnowineveryregionoftheworldandhasthepotentialtoaffectanyone,ofanyage,inanycountry.”Antibioticshaverevolutionizedmedicineinmanyrespects,andcountlessliveshavebeensaved;theirdiscoverywasaturningpointinhumanhistory.Foralmostacentury,bacteria-fightingdrugsknownasantibioticshavehelpedtomanagemanyoftheharmfulbacteriathatcanmakeussick.Butinrecentdecades,theyhavebecomelesseffectiveagainstsometypesofbacteria.Currently,certainbacteriaarenowunbeatablewithtoday’smedicines.Unfortunately,newdrug-resistant“superbugs”haveemerged,whicharestrainsofbacteriathatareresistanttoseveraltypesofantibiotics.Infact,theWorldHealthOrganizationhasclassifiedthisas“aseriousthreat[that]isnolongerapredictionforthefuture,itishappeningrightnowineveryregionoftheworldandhasthepotentialtoaffectanyone,ofanyage,inanycountry.”

  Intheearly1990s,HedyTepplerwastreatingAIDSpatientswithHIV/AIDSatahospitalinPhiladelphia.ShewasalsoservingasaclinicaltrialinvestigatorforPhase1and2MSDstudiesofanewclassofanti-HIVdrugsdesignedtoblocktheHIVproteaseenzymeandthuspreventHIVreplication."Theearlyresultswereexciting.Inashorttime,manypatientsrespondedtotheinvestigationaltreatment,"saysHedy.HerpositiveexperienceduringtheseandsubsequentclinicaltrialswaslargelywhyshejoinedMSDin1996."Iwantedtobemoreinvolvedindrugdevelopmentandclinicaltrialdesign,andMSDwasdoingsomegroundbreakingworkinHIV,"saysHedy,whonowservesasexecutivedirector,ClinicalResearch,InfectiousDiseases,atMSDResearchLaboratories.TheyearbeforeHedyarrived,anotherprominentHIVresearcherandthoughtleaderwaskeepingaclosewatchonMSD'swork.Bach-YenNguyen,nowretired-executivedirector,sectionhead,HCVandHIV,decidedtoleavetheNationalInstitutesofHealthtoworkonMSD'sHIVresearchdevelopmentteam.Bach-YenhadspentyearstreatingAIDSpatientsandworkinginHIVresearchandsawgreatpotentialinMSD'swork."WewerefacedwithanopportunitytohelppatientsinfectedwithHIV."ForBach-Yen,whoalsomadevitalcontributionstothedevelopmentofanotheroneofMSD'smedicinesforthetreatmentofHIV,thedrug'sapprovalcontinuestobehermostmemorablemomentatMSD."Weworkedlonghours.ThereweretimeswhenIcouldn'tattendschooleventswithmyson.WhenpeopleaskedhimwhereIwas,hewouldsay,'MomisbusyhelpingpeoplewithAIDS.'Hewasonly12,butheunderstoodtheimportanceofthework."Withinafewyears,theteamachievedadditionalsuccess:In2011,theFDAapprovedachewabletabletformofthisfirstagentinanewclassofanti-HIVagentsforchildren2yearsandolder,andin2013,approvedgranulesfororalsuspensionforinfants4weeksandolder."Ourpediatricsprogramhasbeenextremelysatisfyingasthereisatremendousneedfornewanti-HIVagentsthatcanbeusedacrosstheentirepediatricagerange,"saysHedy,wholeadstheIsentresspediatricdevelopmentprogram.“EventhoughDr.Alzheimercharacterizedthediseasein1906,itwasn’tuntilthelastfewdecadesthatthediseasebecamerecognizedasarealillnessseparatefromnormalagingandotherformsofdementia,”saidDarryleSchoepp,Ph.D.,vicepresidentandtherapeuticareahead,Neuroscience,MSD.“Nowpeoplearelivinglonger,andwecanseehowthediseaseworks,”saidDavidMichelson,M.D.,vicepresident,ClinicalNeuroscienceResearch,MSD.“Scienceisataplacewherenotonlydoweunderstandmoreaboutit,butweareexploringwaystodosomethingaboutit.”“Newtechnologiesareallowingtheidentificationofearlydiseasesignswhichwehopewillallowustointervenepromptlyinordertosloworhaltprogression.That’stheholygrail.Whatyouwanttodoistohavesomethingthatworksandtobeabletouseitbeforethediseaserobspeopleofwhotheyreallyare,”saidDr.Michelson.HbA1c,ameasureoftheaveragelevelofbloodsugaroverthepasttwotothreemonths,helpsyouandyourdoctorseehowwellyourdiabetestreatmentplanisworking.TherecommendedHbA1c,goalformanyadultswithtype2diabetesislessthan7%;however,thismayvarydependingontheindividual.Highbloodsugarlevelsovertimecanputpeoplewithdiabetesatriskofmanyserioushealthproblems,suchasheartdisease,stroke,kidneydisease,blindnessandnerveproblems.That’swhyitisimportantforpeoplelivingwithdiabetestoworkwiththeirdoctortosetindividualizedgoalsanddevelopapersonalizeddiabetesmanagementplantomanagetheABCsofdiabetes:AforHbA1c,BforbloodpressureandCforcholesterol.

  Antibioticshaverevolutionizedmedicineinmanyrespects,andcountlessliveshavebeensaved;theirdiscoverywasaturningpointinhumanhistory.Foralmostacentury,bacteria-fightingdrugsknownasantibioticshavehelpedtomanagemanyoftheharmfulbacteriathatcanmakeussick.Butinrecentdecades,theyhavebecomelesseffectiveagainstsometypesofbacteria.Currently,certainbacteriaarenowunbeatablewithtoday’smedicines.Unfortunately,newdrug-resistant“superbugs”haveemerged,whicharestrainsofbacteriathatareresistanttoseveraltypesofantibiotics.Infact,theWorldHealthOrganizationhasclassifiedthisas“aseriousthreat[that]isnolongerapredictionforthefuture,itishappeningrightnowineveryregionoftheworldandhasthepotentialtoaffectanyone,ofanyage,inanycountry.”TheImpactofStigmatizationThesenorms,behaviors,andbeliefssurroundinghepatitisCinfectioncanleadtoalienationfromfamilyandfriends,aswellastodiscrimination(perceivedorreal)inhealthservicesandworkplaces.Indeed,manychronichepatitisCpatientsreportfeelingsofstigmatizationandsocialisolationfromtheirfriends,family,andcoworkers.WevetalkedtoHCVinfectedgrandmotherswhoseownchildrenwon’tallowthemtoplaywiththeirgrandchildrenbecausethey’reafraidofsomesortoftransmission,reportsMichaelNinburg,executivedirectoroftheHepatitisEducationProject,aSeattle-basedgroupfoundedin1993toprovideeducation,support,andadvocacyforthoselivingwithhepatitis.ArecentlydiagnosedpatientwhoworkswithMichael’sgroupechoedthissentiment.I'msuperoutgoing.ItalkabouteveryfeelingIhavetomyfriends,justaboutanybody,andmydiagnosiswassomethingIcouldnottalkabout,hesaid.IknewthatIhadtodosomethingaboutit,butIwasashamed.ELIAV:HCV[hepatitisCvirus]infectionisablood-bornedisease.Peoplebecomeinfectedwhenexposedtocontaminatedbloodproductsorcontaminatedsyringesorinjectionequipment.TheincidenceofHCVinfection(thenknownasnon-A/non-Bhepatitis)priorto1965waslow;however,therateincreasedsteadilyintothe1980s.In1988,HCVwasidentifiedandbloodsupplyscreeningforHCVbecameavailablein1992.Peoplegotinfectedandusuallydidn'tknowitbecausetheacuteinfectionistypicallyasymptomatic.Afterprolongedinfection,20to25years,orso,peoplewerepresentingwithadvancedliverdamage,whichcanleadtocirrhosisandeventuallyevenliverfailureorlivercancer.Ahugecohortofbabyboomersgotinfected,didn'tknowit,aregraduallygettingdiagnosedandfindingtheirdiseaseissoadvancedthattheyareapproachingacrisispoint.Theclockistickingonthisproblem.

  HbA1c,ameasureoftheaveragelevelofbloodsugaroverthepasttwotothreemonths,helpsyouandyourdoctorseehowwellyourdiabetestreatmentplanisworking.TherecommendedHbA1c,goalformanyadultswithtype2diabetesislessthan7%;however,thismayvarydependingontheindividual.Highbloodsugarlevelsovertimecanputpeoplewithdiabetesatriskofmanyserioushealthproblems,suchasheartdisease,stroke,kidneydisease,blindnessandnerveproblems.That’swhyitisimportantforpeoplelivingwithdiabetestoworkwiththeirdoctortosetindividualizedgoalsanddevelopapersonalizeddiabetesmanagementplantomanagetheABCsofdiabetes:AforHbA1c,BforbloodpressureandCforcholesterol.In2016,MSDcelebratedits125thanniversaryasaglobalhealthcareleader.Wecreatedthispageasacelebrationofouraccomplishmentsaswellastohighlightwhatwe'reexcitedaboutfortheyearstocome.Thisisanexcitingtimeforourcompanyandtheworld.Today,weareattheforefrontofinventingtoolsforthefightagainstsomeoftheworld’smosturgentglobalhealthchallenges.Thisincludesmorethan30differentcancers,hepatitisC,Alzheimer’sdisease,Ebola,antibiotic-resistantsuperbugs,cardio-metabolicdiseases,andmanyothers.“EventhoughDr.Alzheimercharacterizedthediseasein1906,itwasn’tuntilthelastfewdecadesthatthediseasebecamerecognizedasarealillnessseparatefromnormalagingandotherformsofdementia,”saidDarryleSchoepp,Ph.D.,vicepresidentandtherapeuticareahead,Neuroscience,MSD.“Nowpeoplearelivinglonger,andwecanseehowthediseaseworks,”saidDavidMichelson,M.D.,vicepresident,ClinicalNeuroscienceResearch,MSD.“Scienceisataplacewherenotonlydoweunderstandmoreaboutit,butweareexploringwaystodosomethingaboutit.”“Newtechnologiesareallowingtheidentificationofearlydiseasesignswhichwehopewillallowustointervenepromptlyinordertosloworhaltprogression.That’stheholygrail.Whatyouwanttodoistohavesomethingthatworksandtobeabletouseitbeforethediseaserobspeopleofwhotheyreallyare,”saidDr.Michelson.

  Ourdiscoveryscientists“strivetomaketheimpossiblepossible,”saysJoeMiletich.Andheshouldknow:AstheseniorvicepresidentofDiscoveryPreclinicalandEarlyDevelopment,heleadsateamofresearcherswhoarechargedwithmakingthings“possiblethatweren’tpossiblebefore.”Hecontinues:“Webelievedrugdiscoveryisfoundationalforustocontinuebringingcriticalmedicinestotheworld.”About14,500peopleareinvolvedinscientificresearchatMSD.OurRDcolleaguesarealltaskedwiththesamemission:tosolvethepuzzlesofhumandiseasebiologyandthentranslatethosefindingsintonewtherapiesforpatients.Theyaredriventopushtheboundariesofscienceandtothentransformtheirdiscoveriesintomeaningfulnewtherapeutics.Overthelast20years,MSD’svaccineoperationsinEuropehavebeenpartofajointventurebetweenthecompaniesSanofiandMSD,calledSanofiPasteurMSD(SPMSD).SanofiPasteurMSD—ownedona50/50basisbySanofiPasteurandMSD—wascreatedin1994todevelopandcommercializevaccinesoriginatingfrombothcompanies’pipelinestoimproveandpromotepublichealthin19Europeancountries.Aftercarefullyconsideringourindividualstrategicpriorities,alongsidetheeconomicandregulatoryenvironmentsforvaccineoperationsintheEuropeanUnion,bothcompaniesmutuallyagreedinMarchof2016thatitisinourbestintereststomanageourvaccineproductportfoliosindependently.SanofiPasteurandMSDbelievethatreintegratingtheirrespectivevaccineportfoliosintotheircompanies’operationswillbetterpositionthemtodrivegrowth,executemoreefficiently,optimizevaccinecoverageandbringnewvaccinestomarketmorequickly.Eachcompanywillnowbeabletodefineitsownvaccinesstrategytobenefitpublichealthandcreatevalueforpatients,healthcareprofessionalsandpayers.Throughouttheyear,SPMSDanditsshareholdershavebeenfocusedonasmoothandorderlytransitionwhileachievingtheirpublichealthcaregoalsandupholdingtheircommitmentstotheiremployees,customersandbusinesspartners.Followingthistransitionalperiod,bothcompanieshaveconfirmedthatDec.31,2016willbetheofficialclosingdateoftheendoftheirvaccinesjointventureSanofiPasteurMSD(SPMSD),followingclearancesrecentlygrantedbytheEuropeanCommission.TheImpactofStigmatizationThesenorms,behaviors,andbeliefssurroundinghepatitisCinfectioncanleadtoalienationfromfamilyandfriends,aswellastodiscrimination(perceivedorreal)inhealthservicesandworkplaces.Indeed,manychronichepatitisCpatientsreportfeelingsofstigmatizationandsocialisolationfromtheirfriends,family,andcoworkers.WevetalkedtoHCVinfectedgrandmotherswhoseownchildrenwon’tallowthemtoplaywiththeirgrandchildrenbecausethey’reafraidofsomesortoftransmission,reportsMichaelNinburg,executivedirectoroftheHepatitisEducationProject,aSeattle-basedgroupfoundedin1993toprovideeducation,support,andadvocacyforthoselivingwithhepatitis.ArecentlydiagnosedpatientwhoworkswithMichael’sgroupechoedthissentiment.I'msuperoutgoing.ItalkabouteveryfeelingIhavetomyfriends,justaboutanybody,andmydiagnosiswassomethingIcouldnottalkabout,hesaid.IknewthatIhadtodosomethingaboutit,butIwasashamed.

  TheMSDFellowshipforGlobalHealthisonewayMSDishelpinganswertheglobalhealthneedsoftheunderserved.MSDemployeeswhoparticipateintheprogramarecalledRichardT.ClarkFellows(RTCFellows)inhonorofretiredChairmanandCEORichardT.Clarkandhisphilosophyofpassion,purposeandcommitmenttocorporateresponsibility.Launchedin2012,theprogramoffersMSDemployeesopportunitiestosharetheirskillswithpeoplearoundtheworld.Asmanyas30Fellowsareselectedeachyear;theexpertiseoftheapplicantsismatchedtotheneedsofthepartnerorganizations.Duringthethree-monthassignments,theFellowsareembeddedwithinanon-profitorganizationinthefield.“EventhoughDr.Alzheimercharacterizedthediseasein1906,itwasn’tuntilthelastfewdecadesthatthediseasebecamerecognizedasarealillnessseparatefromnormalagingandotherformsofdementia,”saidDarryleSchoepp,Ph.D.,vicepresidentandtherapeuticareahead,Neuroscience,MSD.“Nowpeoplearelivinglonger,andwecanseehowthediseaseworks,”saidDavidMichelson,M.D.,vicepresident,ClinicalNeuroscienceResearch,MSD.“Scienceisataplacewherenotonlydoweunderstandmoreaboutit,butweareexploringwaystodosomethingaboutit.”“Newtechnologiesareallowingtheidentificationofearlydiseasesignswhichwehopewillallowustointervenepromptlyinordertosloworhaltprogression.That’stheholygrail.Whatyouwanttodoistohavesomethingthatworksandtobeabletouseitbeforethediseaserobspeopleofwhotheyreallyare,”saidDr.Michelson.Overthepast125years,we’veseentheworldchangethroughthepowerofmedicineandinvention.Whileeachpivotalmilestonehasbeenunique,onethingtheyhaveincommonisthatwehaven’tdoneitalone.AtMSD,wehavealwaysbelievedthatgreatmedicalbreakthroughsrelyonteamwork–fromwithinandoutsideofMSD–andourhistoryhasprovenit.Weareproudtohaveworkedinpartnershipwithcompanies,academics,governments,patientorganizations,healthcareprofessionals,nongovernmentalorganizations(NGOs),multilateralorganizationsandothersintheprivatesector--tohelpimprovelivesaroundtheworldandcontinuetosolvesomeoftheworld’smostseriousillnesses.

  “EventhoughDr.Alzheimercharacterizedthediseasein1906,itwasn’tuntilthelastfewdecadesthatthediseasebecamerecognizedasarealillnessseparatefromnormalagingandotherformsofdementia,”saidDarryleSchoepp,Ph.D.,vicepresidentandtherapeuticareahead,Neuroscience,MSD.“Nowpeoplearelivinglonger,andwecanseehowthediseaseworks,”saidDavidMichelson,M.D.,vicepresident,ClinicalNeuroscienceResearch,MSD.“Scienceisataplacewherenotonlydoweunderstandmoreaboutit,butweareexploringwaystodosomethingaboutit.”“Newtechnologiesareallowingtheidentificationofearlydiseasesignswhichwehopewillallowustointervenepromptlyinordertosloworhaltprogression.That’stheholygrail.Whatyouwanttodoistohavesomethingthatworksandtobeabletouseitbeforethediseaserobspeopleofwhotheyreallyare,”saidDr.Michelson.Overthelast20years,MSD’svaccineoperationsinEuropehavebeenpartofajointventurebetweenthecompaniesSanofiandMSD,calledSanofiPasteurMSD(SPMSD).SanofiPasteurMSD—ownedona50/50basisbySanofiPasteurandMSD—wascreatedin1994todevelopandcommercializevaccinesoriginatingfrombothcompanies’pipelinestoimproveandpromotepublichealthin19Europeancountries.Aftercarefullyconsideringourindividualstrategicpriorities,alongsidetheeconomicandregulatoryenvironmentsforvaccineoperationsintheEuropeanUnion,bothcompaniesmutuallyagreedinMarchof2016thatitisinourbestintereststomanageourvaccineproductportfoliosindependently.SanofiPasteurandMSDbelievethatreintegratingtheirrespectivevaccineportfoliosintotheircompanies’operationswillbetterpositionthemtodrivegrowth,executemoreefficiently,optimizevaccinecoverageandbringnewvaccinestomarketmorequickly.Eachcompanywillnowbeabletodefineitsownvaccinesstrategytobenefitpublichealthandcreatevalueforpatients,healthcareprofessionalsandpayers.Throughouttheyear,SPMSDanditsshareholdershavebeenfocusedonasmoothandorderlytransitionwhileachievingtheirpublichealthcaregoalsandupholdingtheircommitmentstotheiremployees,customersandbusinesspartners.Followingthistransitionalperiod,bothcompanieshaveconfirmedthatDec.31,2016willbetheofficialclosingdateoftheendoftheirvaccinesjointventureSanofiPasteurMSD(SPMSD),followingclearancesrecentlygrantedbytheEuropeanCommission.Ourdiscoveryscientists“strivetomaketheimpossiblepossible,”saysJoeMiletich.Andheshouldknow:AstheseniorvicepresidentofDiscoveryPreclinicalandEarlyDevelopment,heleadsateamofresearcherswhoarechargedwithmakingthings“possiblethatweren’tpossiblebefore.”Hecontinues:“Webelievedrugdiscoveryisfoundationalforustocontinuebringingcriticalmedicinestotheworld.”About14,500peopleareinvolvedinscientificresearchatMSD.OurRDcolleaguesarealltaskedwiththesamemission:tosolvethepuzzlesofhumandiseasebiologyandthentranslatethosefindingsintonewtherapiesforpatients.Theyaredriventopushtheboundariesofscienceandtothentransformtheirdiscoveriesintomeaningfulnewtherapeutics.

  Intheearly1990s,HedyTepplerwastreatingAIDSpatientswithHIV/AIDSatahospitalinPhiladelphia.ShewasalsoservingasaclinicaltrialinvestigatorforPhase1and2MSDstudiesofanewclassofanti-HIVdrugsdesignedtoblocktheHIVproteaseenzymeandthuspreventHIVreplication."Theearlyresultswereexciting.Inashorttime,manypatientsrespondedtotheinvestigationaltreatment,"saysHedy.HerpositiveexperienceduringtheseandsubsequentclinicaltrialswaslargelywhyshejoinedMSDin1996."Iwantedtobemoreinvolvedindrugdevelopmentandclinicaltrialdesign,andMSDwasdoingsomegroundbreakingworkinHIV,"saysHedy,whonowservesasexecutivedirector,ClinicalResearch,InfectiousDiseases,atMSDResearchLaboratories.TheyearbeforeHedyarrived,anotherprominentHIVresearcherandthoughtleaderwaskeepingaclosewatchonMSD'swork.Bach-YenNguyen,nowretired-executivedirector,sectionhead,HCVandHIV,decidedtoleavetheNationalInstitutesofHealthtoworkonMSD'sHIVresearchdevelopmentteam.Bach-YenhadspentyearstreatingAIDSpatientsandworkinginHIVresearchandsawgreatpotentialinMSD'swork."WewerefacedwithanopportunitytohelppatientsinfectedwithHIV."ForBach-Yen,whoalsomadevitalcontributionstothedevelopmentofanotheroneofMSD'smedicinesforthetreatmentofHIV,thedrug'sapprovalcontinuestobehermostmemorablemomentatMSD."Weworkedlonghours.ThereweretimeswhenIcouldn'tattendschooleventswithmyson.WhenpeopleaskedhimwhereIwas,hewouldsay,'MomisbusyhelpingpeoplewithAIDS.'Hewasonly12,butheunderstoodtheimportanceofthework."Withinafewyears,theteamachievedadditionalsuccess:In2011,theFDAapprovedachewabletabletformofthisfirstagentinanewclassofanti-HIVagentsforchildren2yearsandolder,andin2013,approvedgranulesfororalsuspensionforinfants4weeksandolder."Ourpediatricsprogramhasbeenextremelysatisfyingasthereisatremendousneedfornewanti-HIVagentsthatcanbeusedacrosstheentirepediatricagerange,"saysHedy,wholeadstheIsentresspediatricdevelopmentprogram.In1987,MSD’sthenCEODr.P.RoyVagelosannounced,inanunprecedentedactofglobalhealthcareleadership,thatMSDwoulddonateivermectin–asmuchasneededforaslongasneeded–withthegoaltohelpeliminateriverblindness.MSDrecognizedinordertoreachthisgoal,manyorganizationswithuniqueskillswouldneedtoworktogetherasateam.Asaresult,MSDcreatedtheMectizanDonationProgram(MDP).OperatingfromtheAtlanta-basedTaskForceforGlobalHealth,theMDPcoordinatesactivitiesbetweenMSD,WHO,theWorldBankandarangeofpublicandprivatestakeholders.In1998,MSDexpandeditscommitmentfromtheMectizanDonationProgramtoincludedonatingivermectinforanotherdisease,lymphaticfilariasis(LF),alsoknownaselephantiasis,inAfricancountriesandYemenwhereitco-existswithriverblindness.ForLF,ivermectinisadministeredwithalbendazole,adrugdonatedbyGSK.ELIAV:HCV[hepatitisCvirus]infectionisablood-bornedisease.Peoplebecomeinfectedwhenexposedtocontaminatedbloodproductsorcontaminatedsyringesorinjectionequipment.TheincidenceofHCVinfection(thenknownasnon-A/non-Bhepatitis)priorto1965waslow;however,therateincreasedsteadilyintothe1980s.In1988,HCVwasidentifiedandbloodsupplyscreeningforHCVbecameavailablein1992.Peoplegotinfectedandusuallydidn'tknowitbecausetheacuteinfectionistypicallyasymptomatic.Afterprolongedinfection,20to25years,orso,peoplewerepresentingwithadvancedliverdamage,whichcanleadtocirrhosisandeventuallyevenliverfailureorlivercancer.Ahugecohortofbabyboomersgotinfected,didn'tknowit,aregraduallygettingdiagnosedandfindingtheirdiseaseissoadvancedthattheyareapproachingacrisispoint.Theclockistickingonthisproblem.

  Overthepast125years,we’veseentheworldchangethroughthepowerofmedicineandinvention.Whileeachpivotalmilestonehasbeenunique,onethingtheyhaveincommonisthatwehaven’tdoneitalone.AtMSD,wehavealwaysbelievedthatgreatmedicalbreakthroughsrelyonteamwork–fromwithinandoutsideofMSD–andourhistoryhasprovenit.Weareproudtohaveworkedinpartnershipwithcompanies,academics,governments,patientorganizations,healthcareprofessionals,nongovernmentalorganizations(NGOs),multilateralorganizationsandothersintheprivatesector--tohelpimprovelivesaroundtheworldandcontinuetosolvesomeoftheworld’smostseriousillnesses.Intheearly1990s,HedyTepplerwastreatingAIDSpatientswithHIV/AIDSatahospitalinPhiladelphia.ShewasalsoservingasaclinicaltrialinvestigatorforPhase1and2MSDstudiesofanewclassofanti-HIVdrugsdesignedtoblocktheHIVproteaseenzymeandthuspreventHIVreplication."Theearlyresultswereexciting.Inashorttime,manypatientsrespondedtotheinvestigationaltreatment,"saysHedy.HerpositiveexperienceduringtheseandsubsequentclinicaltrialswaslargelywhyshejoinedMSDin1996."Iwantedtobemoreinvolvedindrugdevelopmentandclinicaltrialdesign,andMSDwasdoingsomegroundbreakingworkinHIV,"saysHedy,whonowservesasexecutivedirector,ClinicalResearch,InfectiousDiseases,atMSDResearchLaboratories.TheyearbeforeHedyarrived,anotherprominentHIVresearcherandthoughtleaderwaskeepingaclosewatchonMSD'swork.Bach-YenNguyen,nowretired-executivedirector,sectionhead,HCVandHIV,decidedtoleavetheNationalInstitutesofHealthtoworkonMSD'sHIVresearchdevelopmentteam.Bach-YenhadspentyearstreatingAIDSpatientsandworkinginHIVresearchandsawgreatpotentialinMSD'swork."WewerefacedwithanopportunitytohelppatientsinfectedwithHIV."ForBach-Yen,whoalsomadevitalcontributionstothedevelopmentofanotheroneofMSD'smedicinesforthetreatmentofHIV,thedrug'sapprovalcontinuestobehermostmemorablemomentatMSD."Weworkedlonghours.ThereweretimeswhenIcouldn'tattendschooleventswithmyson.WhenpeopleaskedhimwhereIwas,hewouldsay,'MomisbusyhelpingpeoplewithAIDS.'Hewasonly12,butheunderstoodtheimportanceofthework."Withinafewyears,theteamachievedadditionalsuccess:In2011,theFDAapprovedachewabletabletformofthisfirstagentinanewclassofanti-HIVagentsforchildren2yearsandolder,andin2013,approvedgranulesfororalsuspensionforinfants4weeksandolder."Ourpediatricsprogramhasbeenextremelysatisfyingasthereisatremendousneedfornewanti-HIVagentsthatcanbeusedacrosstheentirepediatricagerange,"saysHedy,wholeadstheIsentresspediatricdevelopmentprogram.TheMSDFellowshipforGlobalHealthisonewayMSDishelpinganswertheglobalhealthneedsoftheunderserved.MSDemployeeswhoparticipateintheprogramarecalledRichardT.ClarkFellows(RTCFellows)inhonorofretiredChairmanandCEORichardT.Clarkandhisphilosophyofpassion,purposeandcommitmenttocorporateresponsibility.Launchedin2012,theprogramoffersMSDemployeesopportunitiestosharetheirskillswithpeoplearoundtheworld.Asmanyas30Fellowsareselectedeachyear;theexpertiseoftheapplicantsismatchedtotheneedsofthepartnerorganizations.Duringthethree-monthassignments,theFellowsareembeddedwithinanon-profitorganizationinthefield.

  In1987,MSD’sthenCEODr.P.RoyVagelosannounced,inanunprecedentedactofglobalhealthcareleadership,thatMSDwoulddonateivermectin–asmuchasneededforaslongasneeded–withthegoaltohelpeliminateriverblindness.MSDrecognizedinordertoreachthisgoal,manyorganizationswithuniqueskillswouldneedtoworktogetherasateam.Asaresult,MSDcreatedtheMectizanDonationProgram(MDP).OperatingfromtheAtlanta-basedTaskForceforGlobalHealth,theMDPcoordinatesactivitiesbetweenMSD,WHO,theWorldBankandarangeofpublicandprivatestakeholders.In1998,MSDexpandeditscommitmentfromtheMectizanDonationProgramtoincludedonatingivermectinforanotherdisease,lymphaticfilariasis(LF),alsoknownaselephantiasis,inAfricancountriesandYemenwhereitco-existswithriverblindness.ForLF,ivermectinisadministeredwithalbendazole,adrugdonatedbyGSK.ELIAV:HCV[hepatitisCvirus]infectionisablood-bornedisease.Peoplebecomeinfectedwhenexposedtocontaminatedbloodproductsorcontaminatedsyringesorinjectionequipment.TheincidenceofHCVinfection(thenknownasnon-A/non-Bhepatitis)priorto1965waslow;however,therateincreasedsteadilyintothe1980s.In1988,HCVwasidentifiedandbloodsupplyscreeningforHCVbecameavailablein1992.Peoplegotinfectedandusuallydidn'tknowitbecausetheacuteinfectionistypicallyasymptomatic.Afterprolongedinfection,20to25years,orso,peoplewerepresentingwithadvancedliverdamage,whichcanleadtocirrhosisandeventuallyevenliverfailureorlivercancer.Ahugecohortofbabyboomersgotinfected,didn'tknowit,aregraduallygettingdiagnosedandfindingtheirdiseaseissoadvancedthattheyareapproachingacrisispoint.Theclockistickingonthisproblem.In2016,MSDcelebratedits125thanniversaryasaglobalhealthcareleader.Wecreatedthispageasacelebrationofouraccomplishmentsaswellastohighlightwhatwe'reexcitedaboutfortheyearstocome.Thisisanexcitingtimeforourcompanyandtheworld.Today,weareattheforefrontofinventingtoolsforthefightagainstsomeoftheworld’smosturgentglobalhealthchallenges.Thisincludesmorethan30differentcancers,hepatitisC,Alzheimer’sdisease,Ebola,antibiotic-resistantsuperbugs,cardio-metabolicdiseases,andmanyothers.

  AfyaSerengetiProjectFormorethan15years,haspartneredwiththe(Afyameans"health"inSwahili)intheSerengetiregionofTanzaniaineasternAfrica.Wehelpprovideaccesstopreventivecare,includingrabiesvaccinationsforlocaldogs.Todate,wehavedonatedtwomillionrabiesvaccinestosupportprogramsinIndia,Malawi,SriLanka,TanzaniaandUganda.Wealsoprovidetoolssuchasall-terrainvehiclesandtentstohelpmakesuretheprojectisabletoreachthemostremotecornersoftheregion.Rabiesinhumansanddomesticanimalshasnowbeenvirtuallyeliminatedfromthisareaandhumanhospitalizationsduetorabiddogbiteshavedecreased92percent.Intheearly1990s,HedyTepplerwastreatingAIDSpatientswithHIV/AIDSatahospitalinPhiladelphia.ShewasalsoservingasaclinicaltrialinvestigatorforPhase1and2MSDstudiesofanewclassofanti-HIVdrugsdesignedtoblocktheHIVproteaseenzymeandthuspreventHIVreplication."Theearlyresultswereexciting.Inashorttime,manypatientsrespondedtotheinvestigationaltreatment,"saysHedy.HerpositiveexperienceduringtheseandsubsequentclinicaltrialswaslargelywhyshejoinedMSDin1996."Iwantedtobemoreinvolvedindrugdevelopmentandclinicaltrialdesign,andMSDwasdoingsomegroundbreakingworkinHIV,"saysHedy,whonowservesasexecutivedirector,ClinicalResearch,InfectiousDiseases,atMSDResearchLaboratories.TheyearbeforeHedyarrived,anotherprominentHIVresearcherandthoughtleaderwaskeepingaclosewatchonMSD'swork.Bach-YenNguyen,nowretired-executivedirector,sectionhead,HCVandHIV,decidedtoleavetheNationalInstitutesofHealthtoworkonMSD'sHIVresearchdevelopmentteam.Bach-YenhadspentyearstreatingAIDSpatientsandworkinginHIVresearchandsawgreatpotentialinMSD'swork."WewerefacedwithanopportunitytohelppatientsinfectedwithHIV."ForBach-Yen,whoalsomadevitalcontributionstothedevelopmentofanotheroneofMSD'smedicinesforthetreatmentofHIV,thedrug'sapprovalcontinuestobehermostmemorablemomentatMSD."Weworkedlonghours.ThereweretimeswhenIcouldn'tattendschooleventswithmyson.WhenpeopleaskedhimwhereIwas,hewouldsay,'MomisbusyhelpingpeoplewithAIDS.'Hewasonly12,butheunderstoodtheimportanceofthework."Withinafewyears,theteamachievedadditionalsuccess:In2011,theFDAapprovedachewabletabletformofthisfirstagentinanewclassofanti-HIVagentsforchildren2yearsandolder,andin2013,approvedgranulesfororalsuspensionforinfants4weeksandolder."Ourpediatricsprogramhasbeenextremelysatisfyingasthereisatremendousneedfornewanti-HIVagentsthatcanbeusedacrosstheentirepediatricagerange,"saysHedy,wholeadstheIsentresspediatricdevelopmentprogram.TheImpactofStigmatizationThesenorms,behaviors,andbeliefssurroundinghepatitisCinfectioncanleadtoalienationfromfamilyandfriends,aswellastodiscrimination(perceivedorreal)inhealthservicesandworkplaces.Indeed,manychronichepatitisCpatientsreportfeelingsofstigmatizationandsocialisolationfromtheirfriends,family,andcoworkers.WevetalkedtoHCVinfectedgrandmotherswhoseownchildrenwon’tallowthemtoplaywiththeirgrandchildrenbecausethey’reafraidofsomesortoftransmission,reportsMichaelNinburg,executivedirectoroftheHepatitisEducationProject,aSeattle-basedgroupfoundedin1993toprovideeducation,support,andadvocacyforthoselivingwithhepatitis.ArecentlydiagnosedpatientwhoworkswithMichael’sgroupechoedthissentiment.I'msuperoutgoing.ItalkabouteveryfeelingIhavetomyfriends,justaboutanybody,andmydiagnosiswassomethingIcouldnottalkabout,hesaid.IknewthatIhadtodosomethingaboutit,butIwasashamed.

  “EventhoughDr.Alzheimercharacterizedthediseasein1906,itwasn’tuntilthelastfewdecadesthatthediseasebecamerecognizedasarealillnessseparatefromnormalagingandotherformsofdementia,”saidDarryleSchoepp,Ph.D.,vicepresidentandtherapeuticareahead,Neuroscience,MSD.“Nowpeoplearelivinglonger,andwecanseehowthediseaseworks,”saidDavidMichelson,M.D.,vicepresident,ClinicalNeuroscienceResearch,MSD.“Scienceisataplacewherenotonlydoweunderstandmoreaboutit,butweareexploringwaystodosomethingaboutit.”“Newtechnologiesareallowingtheidentificationofearlydiseasesignswhichwehopewillallowustointervenepromptlyinordertosloworhaltprogression.That’stheholygrail.Whatyouwanttodoistohavesomethingthatworksandtobeabletouseitbeforethediseaserobspeopleofwhotheyreallyare,”saidDr.Michelson.In2016,MSDcelebratedits125thanniversaryasaglobalhealthcareleader.Wecreatedthispageasacelebrationofouraccomplishmentsaswellastohighlightwhatwe'reexcitedaboutfortheyearstocome.Thisisanexcitingtimeforourcompanyandtheworld.Today,weareattheforefrontofinventingtoolsforthefightagainstsomeoftheworld’smosturgentglobalhealthchallenges.Thisincludesmorethan30differentcancers,hepatitisC,Alzheimer’sdisease,Ebola,antibiotic-resistantsuperbugs,cardio-metabolicdiseases,andmanyothers.In2016,MSDcelebratedits125thanniversaryasaglobalhealthcareleader.Wecreatedthispageasacelebrationofouraccomplishmentsaswellastohighlightwhatwe'reexcitedaboutfortheyearstocome.Thisisanexcitingtimeforourcompanyandtheworld.Today,weareattheforefrontofinventingtoolsforthefightagainstsomeoftheworld’smosturgentglobalhealthchallenges.Thisincludesmorethan30differentcancers,hepatitisC,Alzheimer’sdisease,Ebola,antibiotic-resistantsuperbugs,cardio-metabolicdiseases,andmanyothers.

  AfyaSerengetiProjectFormorethan15years,haspartneredwiththe(Afyameans"health"inSwahili)intheSerengetiregionofTanzaniaineasternAfrica.Wehelpprovideaccesstopreventivecare,includingrabiesvaccinationsforlocaldogs.Todate,wehavedonatedtwomillionrabiesvaccinestosupportprogramsinIndia,Malawi,SriLanka,TanzaniaandUganda.Wealsoprovidetoolssuchasall-terrainvehiclesandtentstohelpmakesuretheprojectisabletoreachthemostremotecornersoftheregion.Rabiesinhumansanddomesticanimalshasnowbeenvirtuallyeliminatedfromthisareaandhumanhospitalizationsduetorabiddogbiteshavedecreased92percent.TheImpactofStigmatizationThesenorms,behaviors,andbeliefssurroundinghepatitisCinfectioncanleadtoalienationfromfamilyandfriends,aswellastodiscrimination(perceivedorreal)inhealthservicesandworkplaces.Indeed,manychronichepatitisCpatientsreportfeelingsofstigmatizationandsocialisolationfromtheirfriends,family,andcoworkers.WevetalkedtoHCVinfectedgrandmotherswhoseownchildrenwon’tallowthemtoplaywiththeirgrandchildrenbecausethey’reafraidofsomesortoftransmission,reportsMichaelNinburg,executivedirectoroftheHepatitisEducationProject,aSeattle-basedgroupfoundedin1993toprovideeducation,support,andadvocacyforthoselivingwithhepatitis.ArecentlydiagnosedpatientwhoworkswithMichael’sgroupechoedthissentiment.I'msuperoutgoing.ItalkabouteveryfeelingIhavetomyfriends,justaboutanybody,andmydiagnosiswassomethingIcouldnottalkabout,hesaid.IknewthatIhadtodosomethingaboutit,butIwasashamed.Antibioticshaverevolutionizedmedicineinmanyrespects,andcountlessliveshavebeensaved;theirdiscoverywasaturningpointinhumanhistory.Foralmostacentury,bacteria-fightingdrugsknownasantibioticshavehelpedtomanagemanyoftheharmfulbacteriathatcanmakeussick.Butinrecentdecades,theyhavebecomelesseffectiveagainstsometypesofbacteria.Currently,certainbacteriaarenowunbeatablewithtoday’smedicines.Unfortunately,newdrug-resistant“superbugs”haveemerged,whicharestrainsofbacteriathatareresistanttoseveraltypesofantibiotics.Infact,theWorldHealthOrganizationhasclassifiedthisas“aseriousthreat[that]isnolongerapredictionforthefuture,itishappeningrightnowineveryregionoftheworldandhasthepotentialtoaffectanyone,ofanyage,inanycountry.”

  Overthelast20years,MSD’svaccineoperationsinEuropehavebeenpartofajointventurebetweenthecompaniesSanofiandMSD,calledSanofiPasteurMSD(SPMSD).SanofiPasteurMSD—ownedona50/50basisbySanofiPasteurandMSD—wascreatedin1994todevelopandcommercializevaccinesoriginatingfrombothcompanies’pipelinestoimproveandpromotepublichealthin19Europeancountries.Aftercarefullyconsideringourindividualstrategicpriorities,alongsidetheeconomicandregulatoryenvironmentsforvaccineoperationsintheEuropeanUnion,bothcompaniesmutuallyagreedinMarchof2016thatitisinourbestintereststomanageourvaccineproductportfoliosindependently.SanofiPasteurandMSDbelievethatreintegratingtheirrespectivevaccineportfoliosintotheircompanies’operationswillbetterpositionthemtodrivegrowth,executemoreefficiently,optimizevaccinecoverageandbringnewvaccinestomarketmorequickly.Eachcompanywillnowbeabletodefineitsownvaccinesstrategytobenefitpublichealthandcreatevalueforpatients,healthcareprofessionalsandpayers.Throughouttheyear,SPMSDanditsshareholdershavebeenfocusedonasmoothandorderlytransitionwhileachievingtheirpublichealthcaregoalsandupholdingtheircommitmentstotheiremployees,customersandbusinesspartners.Followingthistransitionalperiod,bothcompanieshaveconfirmedthatDec.31,2016willbetheofficialclosingdateoftheendoftheirvaccinesjointventureSanofiPasteurMSD(SPMSD),followingclearancesrecentlygrantedbytheEuropeanCommission.ELIAV:HCV[hepatitisCvirus]infectionisablood-bornedisease.Peoplebecomeinfectedwhenexposedtocontaminatedbloodproductsorcontaminatedsyringesorinjectionequipment.TheincidenceofHCVinfection(thenknownasnon-A/non-Bhepatitis)priorto1965waslow;however,therateincreasedsteadilyintothe1980s.In1988,HCVwasidentifiedandbloodsupplyscreeningforHCVbecameavailablein1992.Peoplegotinfectedandusuallydidn'tknowitbecausetheacuteinfectionistypicallyasymptomatic.Afterprolongedinfection,20to25years,orso,peoplewerepresentingwithadvancedliverdamage,whichcanleadtocirrhosisandeventuallyevenliverfailureorlivercancer.Ahugecohortofbabyboomersgotinfected,didn'tknowit,aregraduallygettingdiagnosedandfindingtheirdiseaseissoadvancedthattheyareapproachingacrisispoint.Theclockistickingonthisproblem.Overthelast20years,MSD’svaccineoperationsinEuropehavebeenpartofajointventurebetweenthecompaniesSanofiandMSD,calledSanofiPasteurMSD(SPMSD).SanofiPasteurMSD—ownedona50/50basisbySanofiPasteurandMSD—wascreatedin1994todevelopandcommercializevaccinesoriginatingfrombothcompanies’pipelinestoimproveandpromotepublichealthin19Europeancountries.Aftercarefullyconsideringourindividualstrategicpriorities,alongsidetheeconomicandregulatoryenvironmentsforvaccineoperationsintheEuropeanUnion,bothcompaniesmutuallyagreedinMarchof2016thatitisinourbestintereststomanageourvaccineproductportfoliosindependently.SanofiPasteurandMSDbelievethatreintegratingtheirrespectivevaccineportfoliosintotheircompanies’operationswillbetterpositionthemtodrivegrowth,executemoreefficiently,optimizevaccinecoverageandbringnewvaccinestomarketmorequickly.Eachcompanywillnowbeabletodefineitsownvaccinesstrategytobenefitpublichealthandcreatevalueforpatients,healthcareprofessionalsandpayers.Throughouttheyear,SPMSDanditsshareholdershavebeenfocusedonasmoothandorderlytransitionwhileachievingtheirpublichealthcaregoalsandupholdingtheircommitmentstotheiremployees,customersandbusinesspartners.Followingthistransitionalperiod,bothcompanieshaveconfirmedthatDec.31,2016willbetheofficialclosingdateoftheendoftheirvaccinesjointventureSanofiPasteurMSD(SPMSD),followingclearancesrecentlygrantedbytheEuropeanCommission.

  Ourdiscoveryscientists“strivetomaketheimpossiblepossible,”saysJoeMiletich.Andheshouldknow:AstheseniorvicepresidentofDiscoveryPreclinicalandEarlyDevelopment,heleadsateamofresearcherswhoarechargedwithmakingthings“possiblethatweren’tpossiblebefore.”Hecontinues:“Webelievedrugdiscoveryisfoundationalforustocontinuebringingcriticalmedicinestotheworld.”About14,500peopleareinvolvedinscientificresearchatMSD.OurRDcolleaguesarealltaskedwiththesamemission:tosolvethepuzzlesofhumandiseasebiologyandthentranslatethosefindingsintonewtherapiesforpatients.Theyaredriventopushtheboundariesofscienceandtothentransformtheirdiscoveriesintomeaningfulnewtherapeutics.Intheearly1990s,HedyTepplerwastreatingAIDSpatientswithHIV/AIDSatahospitalinPhiladelphia.ShewasalsoservingasaclinicaltrialinvestigatorforPhase1and2MSDstudiesofanewclassofanti-HIVdrugsdesignedtoblocktheHIVproteaseenzymeandthuspreventHIVreplication."Theearlyresultswereexciting.Inashorttime,manypatientsrespondedtotheinvestigationaltreatment,"saysHedy.HerpositiveexperienceduringtheseandsubsequentclinicaltrialswaslargelywhyshejoinedMSDin1996."Iwantedtobemoreinvolvedindrugdevelopmentandclinicaltrialdesign,andMSDwasdoingsomegroundbreakingworkinHIV,"saysHedy,whonowservesasexecutivedirector,ClinicalResearch,InfectiousDiseases,atMSDResearchLaboratories.TheyearbeforeHedyarrived,anotherprominentHIVresearcherandthoughtleaderwaskeepingaclosewatchonMSD'swork.Bach-YenNguyen,nowretired-executivedirector,sectionhead,HCVandHIV,decidedtoleavetheNationalInstitutesofHealthtoworkonMSD'sHIVresearchdevelopmentteam.Bach-YenhadspentyearstreatingAIDSpatientsandworkinginHIVresearchandsawgreatpotentialinMSD'swork."WewerefacedwithanopportunitytohelppatientsinfectedwithHIV."ForBach-Yen,whoalsomadevitalcontributionstothedevelopmentofanotheroneofMSD'smedicinesforthetreatmentofHIV,thedrug'sapprovalcontinuestobehermostmemorablemomentatMSD."Weworkedlonghours.ThereweretimeswhenIcouldn'tattendschooleventswithmyson.WhenpeopleaskedhimwhereIwas,hewouldsay,'MomisbusyhelpingpeoplewithAIDS.'Hewasonly12,butheunderstoodtheimportanceofthework."Withinafewyears,theteamachievedadditionalsuccess:In2011,theFDAapprovedachewabletabletformofthisfirstagentinanewclassofanti-HIVagentsforchildren2yearsandolder,andin2013,approvedgranulesfororalsuspensionforinfants4weeksandolder."Ourpediatricsprogramhasbeenextremelysatisfyingasthereisatremendousneedfornewanti-HIVagentsthatcanbeusedacrosstheentirepediatricagerange,"saysHedy,wholeadstheIsentresspediatricdevelopmentprogram.Intheearly1990s,HedyTepplerwastreatingAIDSpatientswithHIV/AIDSatahospitalinPhiladelphia.ShewasalsoservingasaclinicaltrialinvestigatorforPhase1and2MSDstudiesofanewclassofanti-HIVdrugsdesignedtoblocktheHIVproteaseenzymeandthuspreventHIVreplication."Theearlyresultswereexciting.Inashorttime,manypatientsrespondedtotheinvestigationaltreatment,"saysHedy.HerpositiveexperienceduringtheseandsubsequentclinicaltrialswaslargelywhyshejoinedMSDin1996."Iwantedtobemoreinvolvedindrugdevelopmentandclinicaltrialdesign,andMSDwasdoingsomegroundbreakingworkinHIV,"saysHedy,whonowservesasexecutivedirector,ClinicalResearch,InfectiousDiseases,atMSDResearchLaboratories.TheyearbeforeHedyarrived,anotherprominentHIVresearcherandthoughtleaderwaskeepingaclosewatchonMSD'swork.Bach-YenNguyen,nowretired-executivedirector,sectionhead,HCVandHIV,decidedtoleavetheNationalInstitutesofHealthtoworkonMSD'sHIVresearchdevelopmentteam.Bach-YenhadspentyearstreatingAIDSpatientsandworkinginHIVresearchandsawgreatpotentialinMSD'swork."WewerefacedwithanopportunitytohelppatientsinfectedwithHIV."ForBach-Yen,whoalsomadevitalcontributionstothedevelopmentofanotheroneofMSD'smedicinesforthetreatmentofHIV,thedrug'sapprovalcontinuestobehermostmemorablemomentatMSD."Weworkedlonghours.ThereweretimeswhenIcouldn'tattendschooleventswithmyson.WhenpeopleaskedhimwhereIwas,hewouldsay,'MomisbusyhelpingpeoplewithAIDS.'Hewasonly12,butheunderstoodtheimportanceofthework."Withinafewyears,theteamachievedadditionalsuccess:In2011,theFDAapprovedachewabletabletformofthisfirstagentinanewclassofanti-HIVagentsforchildren2yearsandolder,andin2013,approvedgranulesfororalsuspensionforinfants4weeksandolder."Ourpediatricsprogramhasbeenextremelysatisfyingasthereisatremendousneedfornewanti-HIVagentsthatcanbeusedacrosstheentirepediatricagerange,"saysHedy,wholeadstheIsentresspediatricdevelopmentprogram.

  “EventhoughDr.Alzheimercharacterizedthediseasein1906,itwasn’tuntilthelastfewdecadesthatthediseasebecamerecognizedasarealillnessseparatefromnormalagingandotherformsofdementia,”saidDarryleSchoepp,Ph.D.,vicepresidentandtherapeuticareahead,Neuroscience,MSD.“Nowpeoplearelivinglonger,andwecanseehowthediseaseworks,”saidDavidMichelson,M.D.,vicepresident,ClinicalNeuroscienceResearch,MSD.“Scienceisataplacewherenotonlydoweunderstandmoreaboutit,butweareexploringwaystodosomethingaboutit.”“Newtechnologiesareallowingtheidentificationofearlydiseasesignswhichwehopewillallowustointervenepromptlyinordertosloworhaltprogression.That’stheholygrail.Whatyouwanttodoistohavesomethingthatworksandtobeabletouseitbeforethediseaserobspeopleofwhotheyreallyare,”saidDr.Michelson.TheImpactofStigmatizationThesenorms,behaviors,andbeliefssurroundinghepatitisCinfectioncanleadtoalienationfromfamilyandfriends,aswellastodiscrimination(perceivedorreal)inhealthservicesandworkplaces.Indeed,manychronichepatitisCpatientsreportfeelingsofstigmatizationandsocialisolationfromtheirfriends,family,andcoworkers.WevetalkedtoHCVinfectedgrandmotherswhoseownchildrenwon’tallowthemtoplaywiththeirgrandchildrenbecausethey’reafraidofsomesortoftransmission,reportsMichaelNinburg,executivedirectoroftheHepatitisEducationProject,aSeattle-basedgroupfoundedin1993toprovideeducation,support,andadvocacyforthoselivingwithhepatitis.ArecentlydiagnosedpatientwhoworkswithMichael’sgroupechoedthissentiment.I'msuperoutgoing.ItalkabouteveryfeelingIhavetomyfriends,justaboutanybody,andmydiagnosiswassomethingIcouldnottalkabout,hesaid.IknewthatIhadtodosomethingaboutit,butIwasashamed.TheImpactofStigmatizationThesenorms,behaviors,andbeliefssurroundinghepatitisCinfectioncanleadtoalienationfromfamilyandfriends,aswellastodiscrimination(perceivedorreal)inhealthservicesandworkplaces.Indeed,manychronichepatitisCpatientsreportfeelingsofstigmatizationandsocialisolationfromtheirfriends,family,andcoworkers.WevetalkedtoHCVinfectedgrandmotherswhoseownchildrenwon’tallowthemtoplaywiththeirgrandchildrenbecausethey’reafraidofsomesortoftransmission,reportsMichaelNinburg,executivedirectoroftheHepatitisEducationProject,aSeattle-basedgroupfoundedin1993toprovideeducation,support,andadvocacyforthoselivingwithhepatitis.ArecentlydiagnosedpatientwhoworkswithMichael’sgroupechoedthissentiment.I'msuperoutgoing.ItalkabouteveryfeelingIhavetomyfriends,justaboutanybody,andmydiagnosiswassomethingIcouldnottalkabout,hesaid.IknewthatIhadtodosomethingaboutit,butIwasashamed.

  Intheearly1990s,HedyTepplerwastreatingAIDSpatientswithHIV/AIDSatahospitalinPhiladelphia.ShewasalsoservingasaclinicaltrialinvestigatorforPhase1and2MSDstudiesofanewclassofanti-HIVdrugsdesignedtoblocktheHIVproteaseenzymeandthuspreventHIVreplication."Theearlyresultswereexciting.Inashorttime,manypatientsrespondedtotheinvestigationaltreatment,"saysHedy.HerpositiveexperienceduringtheseandsubsequentclinicaltrialswaslargelywhyshejoinedMSDin1996."Iwantedtobemoreinvolvedindrugdevelopmentandclinicaltrialdesign,andMSDwasdoingsomegroundbreakingworkinHIV,"saysHedy,whonowservesasexecutivedirector,ClinicalResearch,InfectiousDiseases,atMSDResearchLaboratories.TheyearbeforeHedyarrived,anotherprominentHIVresearcherandthoughtleaderwaskeepingaclosewatchonMSD'swork.Bach-YenNguyen,nowretired-executivedirector,sectionhead,HCVandHIV,decidedtoleavetheNationalInstitutesofHealthtoworkonMSD'sHIVresearchdevelopmentteam.Bach-YenhadspentyearstreatingAIDSpatientsandworkinginHIVresearchandsawgreatpotentialinMSD'swork."WewerefacedwithanopportunitytohelppatientsinfectedwithHIV."ForBach-Yen,whoalsomadevitalcontributionstothedevelopmentofanotheroneofMSD'smedicinesforthetreatmentofHIV,thedrug'sapprovalcontinuestobehermostmemorablemomentatMSD."Weworkedlonghours.ThereweretimeswhenIcouldn'tattendschooleventswithmyson.WhenpeopleaskedhimwhereIwas,hewouldsay,'MomisbusyhelpingpeoplewithAIDS.'Hewasonly12,butheunderstoodtheimportanceofthework."Withinafewyears,theteamachievedadditionalsuccess:In2011,theFDAapprovedachewabletabletformofthisfirstagentinanewclassofanti-HIVagentsforchildren2yearsandolder,andin2013,approvedgranulesfororalsuspensionforinfants4weeksandolder."Ourpediatricsprogramhasbeenextremelysatisfyingasthereisatremendousneedfornewanti-HIVagentsthatcanbeusedacrosstheentirepediatricagerange,"saysHedy,wholeadstheIsentresspediatricdevelopmentprogram.AfyaSerengetiProjectFormorethan15years,haspartneredwiththe(Afyameans"health"inSwahili)intheSerengetiregionofTanzaniaineasternAfrica.Wehelpprovideaccesstopreventivecare,includingrabiesvaccinationsforlocaldogs.Todate,wehavedonatedtwomillionrabiesvaccinestosupportprogramsinIndia,Malawi,SriLanka,TanzaniaandUganda.Wealsoprovidetoolssuchasall-terrainvehiclesandtentstohelpmakesuretheprojectisabletoreachthemostremotecornersoftheregion.Rabiesinhumansanddomesticanimalshasnowbeenvirtuallyeliminatedfromthisareaandhumanhospitalizationsduetorabiddogbiteshavedecreased92percent.ELIAV:HCV[hepatitisCvirus]infectionisablood-bornedisease.Peoplebecomeinfectedwhenexposedtocontaminatedbloodproductsorcontaminatedsyringesorinjectionequipment.TheincidenceofHCVinfection(thenknownasnon-A/non-Bhepatitis)priorto1965waslow;however,therateincreasedsteadilyintothe1980s.In1988,HCVwasidentifiedandbloodsupplyscreeningforHCVbecameavailablein1992.Peoplegotinfectedandusuallydidn'tknowitbecausetheacuteinfectionistypicallyasymptomatic.Afterprolongedinfection,20to25years,orso,peoplewerepresentingwithadvancedliverdamage,whichcanleadtocirrhosisandeventuallyevenliverfailureorlivercancer.Ahugecohortofbabyboomersgotinfected,didn'tknowit,aregraduallygettingdiagnosedandfindingtheirdiseaseissoadvancedthattheyareapproachingacrisispoint.Theclockistickingonthisproblem.

  ELIAV:HCV[hepatitisCvirus]infectionisablood-bornedisease.Peoplebecomeinfectedwhenexposedtocontaminatedbloodproductsorcontaminatedsyringesorinjectionequipment.TheincidenceofHCVinfection(thenknownasnon-A/non-Bhepatitis)priorto1965waslow;however,therateincreasedsteadilyintothe1980s.In1988,HCVwasidentifiedandbloodsupplyscreeningforHCVbecameavailablein1992.Peoplegotinfectedandusuallydidn'tknowitbecausetheacuteinfectionistypicallyasymptomatic.Afterprolongedinfection,20to25years,orso,peoplewerepresentingwithadvancedliverdamage,whichcanleadtocirrhosisandeventuallyevenliverfailureorlivercancer.Ahugecohortofbabyboomersgotinfected,didn'tknowit,aregraduallygettingdiagnosedandfindingtheirdiseaseissoadvancedthattheyareapproachingacrisispoint.Theclockistickingonthisproblem.HbA1c,ameasureoftheaveragelevelofbloodsugaroverthepasttwotothreemonths,helpsyouandyourdoctorseehowwellyourdiabetestreatmentplanisworking.TherecommendedHbA1c,goalformanyadultswithtype2diabetesislessthan7%;however,thismayvarydependingontheindividual.Highbloodsugarlevelsovertimecanputpeoplewithdiabetesatriskofmanyserioushealthproblems,suchasheartdisease,stroke,kidneydisease,blindnessandnerveproblems.That’swhyitisimportantforpeoplelivingwithdiabetestoworkwiththeirdoctortosetindividualizedgoalsanddevelopapersonalizeddiabetesmanagementplantomanagetheABCsofdiabetes:AforHbA1c,BforbloodpressureandCforcholesterol.Antibioticshaverevolutionizedmedicineinmanyrespects,andcountlessliveshavebeensaved;theirdiscoverywasaturningpointinhumanhistory.Foralmostacentury,bacteria-fightingdrugsknownasantibioticshavehelpedtomanagemanyoftheharmfulbacteriathatcanmakeussick.Butinrecentdecades,theyhavebecomelesseffectiveagainstsometypesofbacteria.Currently,certainbacteriaarenowunbeatablewithtoday’smedicines.Unfortunately,newdrug-resistant“superbugs”haveemerged,whicharestrainsofbacteriathatareresistanttoseveraltypesofantibiotics.Infact,theWorldHealthOrganizationhasclassifiedthisas“aseriousthreat[that]isnolongerapredictionforthefuture,itishappeningrightnowineveryregionoftheworldandhasthepotentialtoaffectanyone,ofanyage,inanycountry.”

  Overthepast125years,we’veseentheworldchangethroughthepowerofmedicineandinvention.Whileeachpivotalmilestonehasbeenunique,onethingtheyhaveincommonisthatwehaven’tdoneitalone.AtMSD,wehavealwaysbelievedthatgreatmedicalbreakthroughsrelyonteamwork–fromwithinandoutsideofMSD–andourhistoryhasprovenit.Weareproudtohaveworkedinpartnershipwithcompanies,academics,governments,patientorganizations,healthcareprofessionals,nongovernmentalorganizations(NGOs),multilateralorganizationsandothersintheprivatesector--tohelpimprovelivesaroundtheworldandcontinuetosolvesomeoftheworld’smostseriousillnesses.Overthepast125years,we’veseentheworldchangethroughthepowerofmedicineandinvention.Whileeachpivotalmilestonehasbeenunique,onethingtheyhaveincommonisthatwehaven’tdoneitalone.AtMSD,wehavealwaysbelievedthatgreatmedicalbreakthroughsrelyonteamwork–fromwithinandoutsideofMSD–andourhistoryhasprovenit.Weareproudtohaveworkedinpartnershipwithcompanies,academics,governments,patientorganizations,healthcareprofessionals,nongovernmentalorganizations(NGOs),multilateralorganizationsandothersintheprivatesector--tohelpimprovelivesaroundtheworldandcontinuetosolvesomeoftheworld’smostseriousillnesses.“EventhoughDr.Alzheimercharacterizedthediseasein1906,itwasn’tuntilthelastfewdecadesthatthediseasebecamerecognizedasarealillnessseparatefromnormalagingandotherformsofdementia,”saidDarryleSchoepp,Ph.D.,vicepresidentandtherapeuticareahead,Neuroscience,MSD.“Nowpeoplearelivinglonger,andwecanseehowthediseaseworks,”saidDavidMichelson,M.D.,vicepresident,ClinicalNeuroscienceResearch,MSD.“Scienceisataplacewherenotonlydoweunderstandmoreaboutit,butweareexploringwaystodosomethingaboutit.”“Newtechnologiesareallowingtheidentificationofearlydiseasesignswhichwehopewillallowustointervenepromptlyinordertosloworhaltprogression.That’stheholygrail.Whatyouwanttodoistohavesomethingthatworksandtobeabletouseitbeforethediseaserobspeopleofwhotheyreallyare,”saidDr.Michelson.

  “EventhoughDr.Alzheimercharacterizedthediseasein1906,itwasn’tuntilthelastfewdecadesthatthediseasebecamerecognizedasarealillnessseparatefromnormalagingandotherformsofdementia,”saidDarryleSchoepp,Ph.D.,vicepresidentandtherapeuticareahead,Neuroscience,MSD.“Nowpeoplearelivinglonger,andwecanseehowthediseaseworks,”saidDavidMichelson,M.D.,vicepresident,ClinicalNeuroscienceResearch,MSD.“Scienceisataplacewherenotonlydoweunderstandmoreaboutit,butweareexploringwaystodosomethingaboutit.”“Newtechnologiesareallowingtheidentificationofearlydiseasesignswhichwehopewillallowustointervenepromptlyinordertosloworhaltprogression.That’stheholygrail.Whatyouwanttodoistohavesomethingthatworksandtobeabletouseitbeforethediseaserobspeopleofwhotheyreallyare,”saidDr.Michelson.TheMSDFellowshipforGlobalHealthisonewayMSDishelpinganswertheglobalhealthneedsoftheunderserved.MSDemployeeswhoparticipateintheprogramarecalledRichardT.ClarkFellows(RTCFellows)inhonorofretiredChairmanandCEORichardT.Clarkandhisphilosophyofpassion,purposeandcommitmenttocorporateresponsibility.Launchedin2012,theprogramoffersMSDemployeesopportunitiestosharetheirskillswithpeoplearoundtheworld.Asmanyas30Fellowsareselectedeachyear;theexpertiseoftheapplicantsismatchedtotheneedsofthepartnerorganizations.Duringthethree-monthassignments,theFellowsareembeddedwithinanon-profitorganizationinthefield.Ourdiscoveryscientists“strivetomaketheimpossiblepossible,”saysJoeMiletich.Andheshouldknow:AstheseniorvicepresidentofDiscoveryPreclinicalandEarlyDevelopment,heleadsateamofresearcherswhoarechargedwithmakingthings“possiblethatweren’tpossiblebefore.”Hecontinues:“Webelievedrugdiscoveryisfoundationalforustocontinuebringingcriticalmedicinestotheworld.”About14,500peopleareinvolvedinscientificresearchatMSD.OurRDcolleaguesarealltaskedwiththesamemission:tosolvethepuzzlesofhumandiseasebiologyandthentranslatethosefindingsintonewtherapiesforpatients.Theyaredriventopushtheboundariesofscienceandtothentransformtheirdiscoveriesintomeaningfulnewtherapeutics.

  HbA1c,ameasureoftheaveragelevelofbloodsugaroverthepasttwotothreemonths,helpsyouandyourdoctorseehowwellyourdiabetestreatmentplanisworking.TherecommendedHbA1c,goalformanyadultswithtype2diabetesislessthan7%;however,thismayvarydependingontheindividual.Highbloodsugarlevelsovertimecanputpeoplewithdiabetesatriskofmanyserioushealthproblems,suchasheartdisease,stroke,kidneydisease,blindnessandnerveproblems.That’swhyitisimportantforpeoplelivingwithdiabetestoworkwiththeirdoctortosetindividualizedgoalsanddevelopapersonalizeddiabetesmanagementplantomanagetheABCsofdiabetes:AforHbA1c,BforbloodpressureandCforcholesterol.TheImpactofStigmatizationThesenorms,behaviors,andbeliefssurroundinghepatitisCinfectioncanleadtoalienationfromfamilyandfriends,aswellastodiscrimination(perceivedorreal)inhealthservicesandworkplaces.Indeed,manychronichepatitisCpatientsreportfeelingsofstigmatizationandsocialisolationfromtheirfriends,family,andcoworkers.WevetalkedtoHCVinfectedgrandmotherswhoseownchildrenwon’tallowthemtoplaywiththeirgrandchildrenbecausethey’reafraidofsomesortoftransmission,reportsMichaelNinburg,executivedirectoroftheHepatitisEducationProject,aSeattle-basedgroupfoundedin1993toprovideeducation,support,andadvocacyforthoselivingwithhepatitis.ArecentlydiagnosedpatientwhoworkswithMichael’sgroupechoedthissentiment.I'msuperoutgoing.ItalkabouteveryfeelingIhavetomyfriends,justaboutanybody,andmydiagnosiswassomethingIcouldnottalkabout,hesaid.IknewthatIhadtodosomethingaboutit,butIwasashamed.Antibioticshaverevolutionizedmedicineinmanyrespects,andcountlessliveshavebeensaved;theirdiscoverywasaturningpointinhumanhistory.Foralmostacentury,bacteria-fightingdrugsknownasantibioticshavehelpedtomanagemanyoftheharmfulbacteriathatcanmakeussick.Butinrecentdecades,theyhavebecomelesseffectiveagainstsometypesofbacteria.Currently,certainbacteriaarenowunbeatablewithtoday’smedicines.Unfortunately,newdrug-resistant“superbugs”haveemerged,whicharestrainsofbacteriathatareresistanttoseveraltypesofantibiotics.Infact,theWorldHealthOrganizationhasclassifiedthisas“aseriousthreat[that]isnolongerapredictionforthefuture,itishappeningrightnowineveryregionoftheworldandhasthepotentialtoaffectanyone,ofanyage,inanycountry.”

  Overthepast125years,we’veseentheworldchangethroughthepowerofmedicineandinvention.Whileeachpivotalmilestonehasbeenunique,onethingtheyhaveincommonisthatwehaven’tdoneitalone.AtMSD,wehavealwaysbelievedthatgreatmedicalbreakthroughsrelyonteamwork–fromwithinandoutsideofMSD–andourhistoryhasprovenit.Weareproudtohaveworkedinpartnershipwithcompanies,academics,governments,patientorganizations,healthcareprofessionals,nongovernmentalorganizations(NGOs),multilateralorganizationsandothersintheprivatesector--tohelpimprovelivesaroundtheworldandcontinuetosolvesomeoftheworld’smostseriousillnesses.HbA1c,ameasureoftheaveragelevelofbloodsugaroverthepasttwotothreemonths,helpsyouandyourdoctorseehowwellyourdiabetestreatmentplanisworking.TherecommendedHbA1c,goalformanyadultswithtype2diabetesislessthan7%;however,thismayvarydependingontheindividual.Highbloodsugarlevelsovertimecanputpeoplewithdiabetesatriskofmanyserioushealthproblems,suchasheartdisease,stroke,kidneydisease,blindnessandnerveproblems.That’swhyitisimportantforpeoplelivingwithdiabetestoworkwiththeirdoctortosetindividualizedgoalsanddevelopapersonalizeddiabetesmanagementplantomanagetheABCsofdiabetes:AforHbA1c,BforbloodpressureandCforcholesterol.“EventhoughDr.Alzheimercharacterizedthediseasein1906,itwasn’tuntilthelastfewdecadesthatthediseasebecamerecognizedasarealillnessseparatefromnormalagingandotherformsofdementia,”saidDarryleSchoepp,Ph.D.,vicepresidentandtherapeuticareahead,Neuroscience,MSD.“Nowpeoplearelivinglonger,andwecanseehowthediseaseworks,”saidDavidMichelson,M.D.,vicepresident,ClinicalNeuroscienceResearch,MSD.“Scienceisataplacewherenotonlydoweunderstandmoreaboutit,butweareexploringwaystodosomethingaboutit.”“Newtechnologiesareallowingtheidentificationofearlydiseasesignswhichwehopewillallowustointervenepromptlyinordertosloworhaltprogression.That’stheholygrail.Whatyouwanttodoistohavesomethingthatworksandtobeabletouseitbeforethediseaserobspeopleofwhotheyreallyare,”saidDr.Michelson.

  HbA1c,ameasureoftheaveragelevelofbloodsugaroverthepasttwotothreemonths,helpsyouandyourdoctorseehowwellyourdiabetestreatmentplanisworking.TherecommendedHbA1c,goalformanyadultswithtype2diabetesislessthan7%;however,thismayvarydependingontheindividual.Highbloodsugarlevelsovertimecanputpeoplewithdiabetesatriskofmanyserioushealthproblems,suchasheartdisease,stroke,kidneydisease,blindnessandnerveproblems.That’swhyitisimportantforpeoplelivingwithdiabetestoworkwiththeirdoctortosetindividualizedgoalsanddevelopapersonalizeddiabetesmanagementplantomanagetheABCsofdiabetes:AforHbA1c,BforbloodpressureandCforcholesterol.Intheearly1990s,HedyTepplerwastreatingAIDSpatientswithHIV/AIDSatahospitalinPhiladelphia.ShewasalsoservingasaclinicaltrialinvestigatorforPhase1and2MSDstudiesofanewclassofanti-HIVdrugsdesignedtoblocktheHIVproteaseenzymeandthuspreventHIVreplication."Theearlyresultswereexciting.Inashorttime,manypatientsrespondedtotheinvestigationaltreatment,"saysHedy.HerpositiveexperienceduringtheseandsubsequentclinicaltrialswaslargelywhyshejoinedMSDin1996."Iwantedtobemoreinvolvedindrugdevelopmentandclinicaltrialdesign,andMSDwasdoingsomegroundbreakingworkinHIV,"saysHedy,whonowservesasexecutivedirector,ClinicalResearch,InfectiousDiseases,atMSDResearchLaboratories.TheyearbeforeHedyarrived,anotherprominentHIVresearcherandthoughtleaderwaskeepingaclosewatchonMSD'swork.Bach-YenNguyen,nowretired-executivedirector,sectionhead,HCVandHIV,decidedtoleavetheNationalInstitutesofHealthtoworkonMSD'sHIVresearchdevelopmentteam.Bach-YenhadspentyearstreatingAIDSpatientsandworkinginHIVresearchandsawgreatpotentialinMSD'swork."WewerefacedwithanopportunitytohelppatientsinfectedwithHIV."ForBach-Yen,whoalsomadevitalcontributionstothedevelopmentofanotheroneofMSD'smedicinesforthetreatmentofHIV,thedrug'sapprovalcontinuestobehermostmemorablemomentatMSD."Weworkedlonghours.ThereweretimeswhenIcouldn'tattendschooleventswithmyson.WhenpeopleaskedhimwhereIwas,hewouldsay,'MomisbusyhelpingpeoplewithAIDS.'Hewasonly12,butheunderstoodtheimportanceofthework."Withinafewyears,theteamachievedadditionalsuccess:In2011,theFDAapprovedachewabletabletformofthisfirstagentinanewclassofanti-HIVagentsforchildren2yearsandolder,andin2013,approvedgranulesfororalsuspensionforinfants4weeksandolder."Ourpediatricsprogramhasbeenextremelysatisfyingasthereisatremendousneedfornewanti-HIVagentsthatcanbeusedacrosstheentirepediatricagerange,"saysHedy,wholeadstheIsentresspediatricdevelopmentprogram.Overthelast20years,MSD’svaccineoperationsinEuropehavebeenpartofajointventurebetweenthecompaniesSanofiandMSD,calledSanofiPasteurMSD(SPMSD).SanofiPasteurMSD—ownedona50/50basisbySanofiPasteurandMSD—wascreatedin1994todevelopandcommercializevaccinesoriginatingfrombothcompanies’pipelinestoimproveandpromotepublichealthin19Europeancountries.Aftercarefullyconsideringourindividualstrategicpriorities,alongsidetheeconomicandregulatoryenvironmentsforvaccineoperationsintheEuropeanUnion,bothcompaniesmutuallyagreedinMarchof2016thatitisinourbestintereststomanageourvaccineproductportfoliosindependently.SanofiPasteurandMSDbelievethatreintegratingtheirrespectivevaccineportfoliosintotheircompanies’operationswillbetterpositionthemtodrivegrowth,executemoreefficiently,optimizevaccinecoverageandbringnewvaccinestomarketmorequickly.Eachcompanywillnowbeabletodefineitsownvaccinesstrategytobenefitpublichealthandcreatevalueforpatients,healthcareprofessionalsandpayers.Throughouttheyear,SPMSDanditsshareholdershavebeenfocusedonasmoothandorderlytransitionwhileachievingtheirpublichealthcaregoalsandupholdingtheircommitmentstotheiremployees,customersandbusinesspartners.Followingthistransitionalperiod,bothcompanieshaveconfirmedthatDec.31,2016willbetheofficialclosingdateoftheendoftheirvaccinesjointventureSanofiPasteurMSD(SPMSD),followingclearancesrecentlygrantedbytheEuropeanCommission.

  TheMSDFellowshipforGlobalHealthisonewayMSDishelpinganswertheglobalhealthneedsoftheunderserved.MSDemployeeswhoparticipateintheprogramarecalledRichardT.ClarkFellows(RTCFellows)inhonorofretiredChairmanandCEORichardT.Clarkandhisphilosophyofpassion,purposeandcommitmenttocorporateresponsibility.Launchedin2012,theprogramoffersMSDemployeesopportunitiestosharetheirskillswithpeoplearoundtheworld.Asmanyas30Fellowsareselectedeachyear;theexpertiseoftheapplicantsismatchedtotheneedsofthepartnerorganizations.Duringthethree-monthassignments,theFellowsareembeddedwithinanon-profitorganizationinthefield.ELIAV:HCV[hepatitisCvirus]infectionisablood-bornedisease.Peoplebecomeinfectedwhenexposedtocontaminatedbloodproductsorcontaminatedsyringesorinjectionequipment.TheincidenceofHCVinfection(thenknownasnon-A/non-Bhepatitis)priorto1965waslow;however,therateincreasedsteadilyintothe1980s.In1988,HCVwasidentifiedandbloodsupplyscreeningforHCVbecameavailablein1992.Peoplegotinfectedandusuallydidn'tknowitbecausetheacuteinfectionistypicallyasymptomatic.Afterprolongedinfection,20to25years,orso,peoplewerepresentingwithadvancedliverdamage,whichcanleadtocirrhosisandeventuallyevenliverfailureorlivercancer.Ahugecohortofbabyboomersgotinfected,didn'tknowit,aregraduallygettingdiagnosedandfindingtheirdiseaseissoadvancedthattheyareapproachingacrisispoint.Theclockistickingonthisproblem.In2016,MSDcelebratedits125thanniversaryasaglobalhealthcareleader.Wecreatedthispageasacelebrationofouraccomplishmentsaswellastohighlightwhatwe'reexcitedaboutfortheyearstocome.Thisisanexcitingtimeforourcompanyandtheworld.Today,weareattheforefrontofinventingtoolsforthefightagainstsomeoftheworld’smosturgentglobalhealthchallenges.Thisincludesmorethan30differentcancers,hepatitisC,Alzheimer’sdisease,Ebola,antibiotic-resistantsuperbugs,cardio-metabolicdiseases,andmanyothers.

  In1987,MSD’sthenCEODr.P.RoyVagelosannounced,inanunprecedentedactofglobalhealthcareleadership,thatMSDwoulddonateivermectin–asmuchasneededforaslongasneeded–withthegoaltohelpeliminateriverblindness.MSDrecognizedinordertoreachthisgoal,manyorganizationswithuniqueskillswouldneedtoworktogetherasateam.Asaresult,MSDcreatedtheMectizanDonationProgram(MDP).OperatingfromtheAtlanta-basedTaskForceforGlobalHealth,theMDPcoordinatesactivitiesbetweenMSD,WHO,theWorldBankandarangeofpublicandprivatestakeholders.In1998,MSDexpandeditscommitmentfromtheMectizanDonationProgramtoincludedonatingivermectinforanotherdisease,lymphaticfilariasis(LF),alsoknownaselephantiasis,inAfricancountriesandYemenwhereitco-existswithriverblindness.ForLF,ivermectinisadministeredwithalbendazole,adrugdonatedbyGSK.In1987,MSD’sthenCEODr.P.RoyVagelosannounced,inanunprecedentedactofglobalhealthcareleadership,thatMSDwoulddonateivermectin–asmuchasneededforaslongasneeded–withthegoaltohelpeliminateriverblindness.MSDrecognizedinordertoreachthisgoal,manyorganizationswithuniqueskillswouldneedtoworktogetherasateam.Asaresult,MSDcreatedtheMectizanDonationProgram(MDP).OperatingfromtheAtlanta-basedTaskForceforGlobalHealth,theMDPcoordinatesactivitiesbetweenMSD,WHO,theWorldBankandarangeofpublicandprivatestakeholders.In1998,MSDexpandeditscommitmentfromtheMectizanDonationProgramtoincludedonatingivermectinforanotherdisease,lymphaticfilariasis(LF),alsoknownaselephantiasis,inAfricancountriesandYemenwhereitco-existswithriverblindness.ForLF,ivermectinisadministeredwithalbendazole,adrugdonatedbyGSK.ELIAV:HCV[hepatitisCvirus]infectionisablood-bornedisease.Peoplebecomeinfectedwhenexposedtocontaminatedbloodproductsorcontaminatedsyringesorinjectionequipment.TheincidenceofHCVinfection(thenknownasnon-A/non-Bhepatitis)priorto1965waslow;however,therateincreasedsteadilyintothe1980s.In1988,HCVwasidentifiedandbloodsupplyscreeningforHCVbecameavailablein1992.Peoplegotinfectedandusuallydidn'tknowitbecausetheacuteinfectionistypicallyasymptomatic.Afterprolongedinfection,20to25years,orso,peoplewerepresentingwithadvancedliverdamage,whichcanleadtocirrhosisandeventuallyevenliverfailureorlivercancer.Ahugecohortofbabyboomersgotinfected,didn'tknowit,aregraduallygettingdiagnosedandfindingtheirdiseaseissoadvancedthattheyareapproachingacrisispoint.Theclockistickingonthisproblem.

  In1987,MSD’sthenCEODr.P.RoyVagelosannounced,inanunprecedentedactofglobalhealthcareleadership,thatMSDwoulddonateivermectin–asmuchasneededforaslongasneeded–withthegoaltohelpeliminateriverblindness.MSDrecognizedinordertoreachthisgoal,manyorganizationswithuniqueskillswouldneedtoworktogetherasateam.Asaresult,MSDcreatedtheMectizanDonationProgram(MDP).OperatingfromtheAtlanta-basedTaskForceforGlobalHealth,theMDPcoordinatesactivitiesbetweenMSD,WHO,theWorldBankandarangeofpublicandprivatestakeholders.In1998,MSDexpandeditscommitmentfromtheMectizanDonationProgramtoincludedonatingivermectinforanotherdisease,lymphaticfilariasis(LF),alsoknownaselephantiasis,inAfricancountriesandYemenwhereitco-existswithriverblindness.ForLF,ivermectinisadministeredwithalbendazole,adrugdonatedbyGSK.Intheearly1990s,HedyTepplerwastreatingAIDSpatientswithHIV/AIDSatahospitalinPhiladelphia.ShewasalsoservingasaclinicaltrialinvestigatorforPhase1and2MSDstudiesofanewclassofanti-HIVdrugsdesignedtoblocktheHIVproteaseenzymeandthuspreventHIVreplication."Theearlyresultswereexciting.Inashorttime,manypatientsrespondedtotheinvestigationaltreatment,"saysHedy.HerpositiveexperienceduringtheseandsubsequentclinicaltrialswaslargelywhyshejoinedMSDin1996."Iwantedtobemoreinvolvedindrugdevelopmentandclinicaltrialdesign,andMSDwasdoingsomegroundbreakingworkinHIV,"saysHedy,whonowservesasexecutivedirector,ClinicalResearch,InfectiousDiseases,atMSDResearchLaboratories.TheyearbeforeHedyarrived,anotherprominentHIVresearcherandthoughtleaderwaskeepingaclosewatchonMSD'swork.Bach-YenNguyen,nowretired-executivedirector,sectionhead,HCVandHIV,decidedtoleavetheNationalInstitutesofHealthtoworkonMSD'sHIVresearchdevelopmentteam.Bach-YenhadspentyearstreatingAIDSpatientsandworkinginHIVresearchandsawgreatpotentialinMSD'swork."WewerefacedwithanopportunitytohelppatientsinfectedwithHIV."ForBach-Yen,whoalsomadevitalcontributionstothedevelopmentofanotheroneofMSD'smedicinesforthetreatmentofHIV,thedrug'sapprovalcontinuestobehermostmemorablemomentatMSD."Weworkedlonghours.ThereweretimeswhenIcouldn'tattendschooleventswithmyson.WhenpeopleaskedhimwhereIwas,hewouldsay,'MomisbusyhelpingpeoplewithAIDS.'Hewasonly12,butheunderstoodtheimportanceofthework."Withinafewyears,theteamachievedadditionalsuccess:In2011,theFDAapprovedachewabletabletformofthisfirstagentinanewclassofanti-HIVagentsforchildren2yearsandolder,andin2013,approvedgranulesfororalsuspensionforinfants4weeksandolder."Ourpediatricsprogramhasbeenextremelysatisfyingasthereisatremendousneedfornewanti-HIVagentsthatcanbeusedacrosstheentirepediatricagerange,"saysHedy,wholeadstheIsentresspediatricdevelopmentprogram.In2016,MSDcelebratedits125thanniversaryasaglobalhealthcareleader.Wecreatedthispageasacelebrationofouraccomplishmentsaswellastohighlightwhatwe'reexcitedaboutfortheyearstocome.Thisisanexcitingtimeforourcompanyandtheworld.Today,weareattheforefrontofinventingtoolsforthefightagainstsomeoftheworld’smosturgentglobalhealthchallenges.Thisincludesmorethan30differentcancers,hepatitisC,Alzheimer’sdisease,Ebola,antibiotic-resistantsuperbugs,cardio-metabolicdiseases,andmanyothers.

  “EventhoughDr.Alzheimercharacterizedthediseasein1906,itwasn’tuntilthelastfewdecadesthatthediseasebecamerecognizedasarealillnessseparatefromnormalagingandotherformsofdementia,”saidDarryleSchoepp,Ph.D.,vicepresidentandtherapeuticareahead,Neuroscience,MSD.“Nowpeoplearelivinglonger,andwecanseehowthediseaseworks,”saidDavidMichelson,M.D.,vicepresident,ClinicalNeuroscienceResearch,MSD.“Scienceisataplacewherenotonlydoweunderstandmoreaboutit,butweareexploringwaystodosomethingaboutit.”“Newtechnologiesareallowingtheidentificationofearlydiseasesignswhichwehopewillallowustointervenepromptlyinordertosloworhaltprogression.That’stheholygrail.Whatyouwanttodoistohavesomethingthatworksandtobeabletouseitbeforethediseaserobspeopleofwhotheyreallyare,”saidDr.Michelson.AfyaSerengetiProjectFormorethan15years,haspartneredwiththe(Afyameans"health"inSwahili)intheSerengetiregionofTanzaniaineasternAfrica.Wehelpprovideaccesstopreventivecare,includingrabiesvaccinationsforlocaldogs.Todate,wehavedonatedtwomillionrabiesvaccinestosupportprogramsinIndia,Malawi,SriLanka,TanzaniaandUganda.Wealsoprovidetoolssuchasall-terrainvehiclesandtentstohelpmakesuretheprojectisabletoreachthemostremotecornersoftheregion.Rabiesinhumansanddomesticanimalshasnowbeenvirtuallyeliminatedfromthisareaandhumanhospitalizationsduetorabiddogbiteshavedecreased92percent.Overthepast125years,we’veseentheworldchangethroughthepowerofmedicineandinvention.Whileeachpivotalmilestonehasbeenunique,onethingtheyhaveincommonisthatwehaven’tdoneitalone.AtMSD,wehavealwaysbelievedthatgreatmedicalbreakthroughsrelyonteamwork–fromwithinandoutsideofMSD–andourhistoryhasprovenit.Weareproudtohaveworkedinpartnershipwithcompanies,academics,governments,patientorganizations,healthcareprofessionals,nongovernmentalorganizations(NGOs),multilateralorganizationsandothersintheprivatesector--tohelpimprovelivesaroundtheworldandcontinuetosolvesomeoftheworld’smostseriousillnesses.

  ELIAV:HCV[hepatitisCvirus]infectionisablood-bornedisease.Peoplebecomeinfectedwhenexposedtocontaminatedbloodproductsorcontaminatedsyringesorinjectionequipment.TheincidenceofHCVinfection(thenknownasnon-A/non-Bhepatitis)priorto1965waslow;however,therateincreasedsteadilyintothe1980s.In1988,HCVwasidentifiedandbloodsupplyscreeningforHCVbecameavailablein1992.Peoplegotinfectedandusuallydidn'tknowitbecausetheacuteinfectionistypicallyasymptomatic.Afterprolongedinfection,20to25years,orso,peoplewerepresentingwithadvancedliverdamage,whichcanleadtocirrhosisandeventuallyevenliverfailureorlivercancer.Ahugecohortofbabyboomersgotinfected,didn'tknowit,aregraduallygettingdiagnosedandfindingtheirdiseaseissoadvancedthattheyareapproachingacrisispoint.Theclockistickingonthisproblem.In1987,MSD’sthenCEODr.P.RoyVagelosannounced,inanunprecedentedactofglobalhealthcareleadership,thatMSDwoulddonateivermectin–asmuchasneededforaslongasneeded–withthegoaltohelpeliminateriverblindness.MSDrecognizedinordertoreachthisgoal,manyorganizationswithuniqueskillswouldneedtoworktogetherasateam.Asaresult,MSDcreatedtheMectizanDonationProgram(MDP).OperatingfromtheAtlanta-basedTaskForceforGlobalHealth,theMDPcoordinatesactivitiesbetweenMSD,WHO,theWorldBankandarangeofpublicandprivatestakeholders.In1998,MSDexpandeditscommitmentfromtheMectizanDonationProgramtoincludedonatingivermectinforanotherdisease,lymphaticfilariasis(LF),alsoknownaselephantiasis,inAfricancountriesandYemenwhereitco-existswithriverblindness.ForLF,ivermectinisadministeredwithalbendazole,adrugdonatedbyGSK.“EventhoughDr.Alzheimercharacterizedthediseasein1906,itwasn’tuntilthelastfewdecadesthatthediseasebecamerecognizedasarealillnessseparatefromnormalagingandotherformsofdementia,”saidDarryleSchoepp,Ph.D.,vicepresidentandtherapeuticareahead,Neuroscience,MSD.“Nowpeoplearelivinglonger,andwecanseehowthediseaseworks,”saidDavidMichelson,M.D.,vicepresident,ClinicalNeuroscienceResearch,MSD.“Scienceisataplacewherenotonlydoweunderstandmoreaboutit,butweareexploringwaystodosomethingaboutit.”“Newtechnologiesareallowingtheidentificationofearlydiseasesignswhichwehopewillallowustointervenepromptlyinordertosloworhaltprogression.That’stheholygrail.Whatyouwanttodoistohavesomethingthatworksandtobeabletouseitbeforethediseaserobspeopleofwhotheyreallyare,”saidDr.Michelson.

  Ourdiscoveryscientists“strivetomaketheimpossiblepossible,”saysJoeMiletich.Andheshouldknow:AstheseniorvicepresidentofDiscoveryPreclinicalandEarlyDevelopment,heleadsateamofresearcherswhoarechargedwithmakingthings“possiblethatweren’tpossiblebefore.”Hecontinues:“Webelievedrugdiscoveryisfoundationalforustocontinuebringingcriticalmedicinestotheworld.”About14,500peopleareinvolvedinscientificresearchatMSD.OurRDcolleaguesarealltaskedwiththesamemission:tosolvethepuzzlesofhumandiseasebiologyandthentranslatethosefindingsintonewtherapiesforpatients.Theyaredriventopushtheboundariesofscienceandtothentransformtheirdiscoveriesintomeaningfulnewtherapeutics.AfyaSerengetiProjectFormorethan15years,haspartneredwiththe(Afyameans"health"inSwahili)intheSerengetiregionofTanzaniaineasternAfrica.Wehelpprovideaccesstopreventivecare,includingrabiesvaccinationsforlocaldogs.Todate,wehavedonatedtwomillionrabiesvaccinestosupportprogramsinIndia,Malawi,SriLanka,TanzaniaandUganda.Wealsoprovidetoolssuchasall-terrainvehiclesandtentstohelpmakesuretheprojectisabletoreachthemostremotecornersoftheregion.Rabiesinhumansanddomesticanimalshasnowbeenvirtuallyeliminatedfromthisareaandhumanhospitalizationsduetorabiddogbiteshavedecreased92percent.AfyaSerengetiProjectFormorethan15years,haspartneredwiththe(Afyameans"health"inSwahili)intheSerengetiregionofTanzaniaineasternAfrica.Wehelpprovideaccesstopreventivecare,includingrabiesvaccinationsforlocaldogs.Todate,wehavedonatedtwomillionrabiesvaccinestosupportprogramsinIndia,Malawi,SriLanka,TanzaniaandUganda.Wealsoprovidetoolssuchasall-terrainvehiclesandtentstohelpmakesuretheprojectisabletoreachthemostremotecornersoftheregion.Rabiesinhumansanddomesticanimalshasnowbeenvirtuallyeliminatedfromthisareaandhumanhospitalizationsduetorabiddogbiteshavedecreased92percent.

  Overthepast125years,we’veseentheworldchangethroughthepowerofmedicineandinvention.Whileeachpivotalmilestonehasbeenunique,onethingtheyhaveincommonisthatwehaven’tdoneitalone.AtMSD,wehavealwaysbelievedthatgreatmedicalbreakthroughsrelyonteamwork–fromwithinandoutsideofMSD–andourhistoryhasprovenit.Weareproudtohaveworkedinpartnershipwithcompanies,academics,governments,patientorganizations,healthcareprofessionals,nongovernmentalorganizations(NGOs),multilateralorganizationsandothersintheprivatesector--tohelpimprovelivesaroundtheworldandcontinuetosolvesomeoftheworld’smostseriousillnesses.TheMSDFellowshipforGlobalHealthisonewayMSDishelpinganswertheglobalhealthneedsoftheunderserved.MSDemployeeswhoparticipateintheprogramarecalledRichardT.ClarkFellows(RTCFellows)inhonorofretiredChairmanandCEORichardT.Clarkandhisphilosophyofpassion,purposeandcommitmenttocorporateresponsibility.Launchedin2012,theprogramoffersMSDemployeesopportunitiestosharetheirskillswithpeoplearoundtheworld.Asmanyas30Fellowsareselectedeachyear;theexpertiseoftheapplicantsismatchedtotheneedsofthepartnerorganizations.Duringthethree-monthassignments,theFellowsareembeddedwithinanon-profitorganizationinthefield.Overthelast20years,MSD’svaccineoperationsinEuropehavebeenpartofajointventurebetweenthecompaniesSanofiandMSD,calledSanofiPasteurMSD(SPMSD).SanofiPasteurMSD—ownedona50/50basisbySanofiPasteurandMSD—wascreatedin1994todevelopandcommercializevaccinesoriginatingfrombothcompanies’pipelinestoimproveandpromotepublichealthin19Europeancountries.Aftercarefullyconsideringourindividualstrategicpriorities,alongsidetheeconomicandregulatoryenvironmentsforvaccineoperationsintheEuropeanUnion,bothcompaniesmutuallyagreedinMarchof2016thatitisinourbestintereststomanageourvaccineproductportfoliosindependently.SanofiPasteurandMSDbelievethatreintegratingtheirrespectivevaccineportfoliosintotheircompanies’operationswillbetterpositionthemtodrivegrowth,executemoreefficiently,optimizevaccinecoverageandbringnewvaccinestomarketmorequickly.Eachcompanywillnowbeabletodefineitsownvaccinesstrategytobenefitpublichealthandcreatevalueforpatients,healthcareprofessionalsandpayers.Throughouttheyear,SPMSDanditsshareholdershavebeenfocusedonasmoothandorderlytransitionwhileachievingtheirpublichealthcaregoalsandupholdingtheircommitmentstotheiremployees,customersandbusinesspartners.Followingthistransitionalperiod,bothcompanieshaveconfirmedthatDec.31,2016willbetheofficialclosingdateoftheendoftheirvaccinesjointventureSanofiPasteurMSD(SPMSD),followingclearancesrecentlygrantedbytheEuropeanCommission.

  “EventhoughDr.Alzheimercharacterizedthediseasein1906,itwasn’tuntilthelastfewdecadesthatthediseasebecamerecognizedasarealillnessseparatefromnormalagingandotherformsofdementia,”saidDarryleSchoepp,Ph.D.,vicepresidentandtherapeuticareahead,Neuroscience,MSD.“Nowpeoplearelivinglonger,andwecanseehowthediseaseworks,”saidDavidMichelson,M.D.,vicepresident,ClinicalNeuroscienceResearch,MSD.“Scienceisataplacewherenotonlydoweunderstandmoreaboutit,butweareexploringwaystodosomethingaboutit.”“Newtechnologiesareallowingtheidentificationofearlydiseasesignswhichwehopewillallowustointervenepromptlyinordertosloworhaltprogression.That’stheholygrail.Whatyouwanttodoistohavesomethingthatworksandtobeabletouseitbeforethediseaserobspeopleofwhotheyreallyare,”saidDr.Michelson.In1987,MSD’sthenCEODr.P.RoyVagelosannounced,inanunprecedentedactofglobalhealthcareleadership,thatMSDwoulddonateivermectin–asmuchasneededforaslongasneeded–withthegoaltohelpeliminateriverblindness.MSDrecognizedinordertoreachthisgoal,manyorganizationswithuniqueskillswouldneedtoworktogetherasateam.Asaresult,MSDcreatedtheMectizanDonationProgram(MDP).OperatingfromtheAtlanta-basedTaskForceforGlobalHealth,theMDPcoordinatesactivitiesbetweenMSD,WHO,theWorldBankandarangeofpublicandprivatestakeholders.In1998,MSDexpandeditscommitmentfromtheMectizanDonationProgramtoincludedonatingivermectinforanotherdisease,lymphaticfilariasis(LF),alsoknownaselephantiasis,inAfricancountriesandYemenwhereitco-existswithriverblindness.ForLF,ivermectinisadministeredwithalbendazole,adrugdonatedbyGSK.Ourdiscoveryscientists“strivetomaketheimpossiblepossible,”saysJoeMiletich.Andheshouldknow:AstheseniorvicepresidentofDiscoveryPreclinicalandEarlyDevelopment,heleadsateamofresearcherswhoarechargedwithmakingthings“possiblethatweren’tpossiblebefore.”Hecontinues:“Webelievedrugdiscoveryisfoundationalforustocontinuebringingcriticalmedicinestotheworld.”About14,500peopleareinvolvedinscientificresearchatMSD.OurRDcolleaguesarealltaskedwiththesamemission:tosolvethepuzzlesofhumandiseasebiologyandthentranslatethosefindingsintonewtherapiesforpatients.Theyaredriventopushtheboundariesofscienceandtothentransformtheirdiscoveriesintomeaningfulnewtherapeutics.

  In1987,MSD’sthenCEODr.P.RoyVagelosannounced,inanunprecedentedactofglobalhealthcareleadership,thatMSDwoulddonateivermectin–asmuchasneededforaslongasneeded–withthegoaltohelpeliminateriverblindness.MSDrecognizedinordertoreachthisgoal,manyorganizationswithuniqueskillswouldneedtoworktogetherasateam.Asaresult,MSDcreatedtheMectizanDonationProgram(MDP).OperatingfromtheAtlanta-basedTaskForceforGlobalHealth,theMDPcoordinatesactivitiesbetweenMSD,WHO,theWorldBankandarangeofpublicandprivatestakeholders.In1998,MSDexpandeditscommitmentfromtheMectizanDonationProgramtoincludedonatingivermectinforanotherdisease,lymphaticfilariasis(LF),alsoknownaselephantiasis,inAfricancountriesandYemenwhereitco-existswithriverblindness.ForLF,ivermectinisadministeredwithalbendazole,adrugdonatedbyGSK.HbA1c,ameasureoftheaveragelevelofbloodsugaroverthepasttwotothreemonths,helpsyouandyourdoctorseehowwellyourdiabetestreatmentplanisworking.TherecommendedHbA1c,goalformanyadultswithtype2diabetesislessthan7%;however,thismayvarydependingontheindividual.Highbloodsugarlevelsovertimecanputpeoplewithdiabetesatriskofmanyserioushealthproblems,suchasheartdisease,stroke,kidneydisease,blindnessandnerveproblems.That’swhyitisimportantforpeoplelivingwithdiabetestoworkwiththeirdoctortosetindividualizedgoalsanddevelopapersonalizeddiabetesmanagementplantomanagetheABCsofdiabetes:AforHbA1c,BforbloodpressureandCforcholesterol.ELIAV:HCV[hepatitisCvirus]infectionisablood-bornedisease.Peoplebecomeinfectedwhenexposedtocontaminatedbloodproductsorcontaminatedsyringesorinjectionequipment.TheincidenceofHCVinfection(thenknownasnon-A/non-Bhepatitis)priorto1965waslow;however,therateincreasedsteadilyintothe1980s.In1988,HCVwasidentifiedandbloodsupplyscreeningforHCVbecameavailablein1992.Peoplegotinfectedandusuallydidn'tknowitbecausetheacuteinfectionistypicallyasymptomatic.Afterprolongedinfection,20to25years,orso,peoplewerepresentingwithadvancedliverdamage,whichcanleadtocirrhosisandeventuallyevenliverfailureorlivercancer.Ahugecohortofbabyboomersgotinfected,didn'tknowit,aregraduallygettingdiagnosedandfindingtheirdiseaseissoadvancedthattheyareapproachingacrisispoint.Theclockistickingonthisproblem.

  In1987,MSD’sthenCEODr.P.RoyVagelosannounced,inanunprecedentedactofglobalhealthcareleadership,thatMSDwoulddonateivermectin–asmuchasneededforaslongasneeded–withthegoaltohelpeliminateriverblindness.MSDrecognizedinordertoreachthisgoal,manyorganizationswithuniqueskillswouldneedtoworktogetherasateam.Asaresult,MSDcreatedtheMectizanDonationProgram(MDP).OperatingfromtheAtlanta-basedTaskForceforGlobalHealth,theMDPcoordinatesactivitiesbetweenMSD,WHO,theWorldBankandarangeofpublicandprivatestakeholders.In1998,MSDexpandeditscommitmentfromtheMectizanDonationProgramtoincludedonatingivermectinforanotherdisease,lymphaticfilariasis(LF),alsoknownaselephantiasis,inAfricancountriesandYemenwhereitco-existswithriverblindness.ForLF,ivermectinisadministeredwithalbendazole,adrugdonatedbyGSK.Overthelast20years,MSD’svaccineoperationsinEuropehavebeenpartofajointventurebetweenthecompaniesSanofiandMSD,calledSanofiPasteurMSD(SPMSD).SanofiPasteurMSD—ownedona50/50basisbySanofiPasteurandMSD—wascreatedin1994todevelopandcommercializevaccinesoriginatingfrombothcompanies’pipelinestoimproveandpromotepublichealthin19Europeancountries.Aftercarefullyconsideringourindividualstrategicpriorities,alongsidetheeconomicandregulatoryenvironmentsforvaccineoperationsintheEuropeanUnion,bothcompaniesmutuallyagreedinMarchof2016thatitisinourbestintereststomanageourvaccineproductportfoliosindependently.SanofiPasteurandMSDbelievethatreintegratingtheirrespectivevaccineportfoliosintotheircompanies’operationswillbetterpositionthemtodrivegrowth,executemoreefficiently,optimizevaccinecoverageandbringnewvaccinestomarketmorequickly.Eachcompanywillnowbeabletodefineitsownvaccinesstrategytobenefitpublichealthandcreatevalueforpatients,healthcareprofessionalsandpayers.Throughouttheyear,SPMSDanditsshareholdershavebeenfocusedonasmoothandorderlytransitionwhileachievingtheirpublichealthcaregoalsandupholdingtheircommitmentstotheiremployees,customersandbusinesspartners.Followingthistransitionalperiod,bothcompanieshaveconfirmedthatDec.31,2016willbetheofficialclosingdateoftheendoftheirvaccinesjointventureSanofiPasteurMSD(SPMSD),followingclearancesrecentlygrantedbytheEuropeanCommission.In1987,MSD’sthenCEODr.P.RoyVagelosannounced,inanunprecedentedactofglobalhealthcareleadership,thatMSDwoulddonateivermectin–asmuchasneededforaslongasneeded–withthegoaltohelpeliminateriverblindness.MSDrecognizedinordertoreachthisgoal,manyorganizationswithuniqueskillswouldneedtoworktogetherasateam.Asaresult,MSDcreatedtheMectizanDonationProgram(MDP).OperatingfromtheAtlanta-basedTaskForceforGlobalHealth,theMDPcoordinatesactivitiesbetweenMSD,WHO,theWorldBankandarangeofpublicandprivatestakeholders.In1998,MSDexpandeditscommitmentfromtheMectizanDonationProgramtoincludedonatingivermectinforanotherdisease,lymphaticfilariasis(LF),alsoknownaselephantiasis,inAfricancountriesandYemenwhereitco-existswithriverblindness.ForLF,ivermectinisadministeredwithalbendazole,adrugdonatedbyGSK.

  AfyaSerengetiProjectFormorethan15years,haspartneredwiththe(Afyameans"health"inSwahili)intheSerengetiregionofTanzaniaineasternAfrica.Wehelpprovideaccesstopreventivecare,includingrabiesvaccinationsforlocaldogs.Todate,wehavedonatedtwomillionrabiesvaccinestosupportprogramsinIndia,Malawi,SriLanka,TanzaniaandUganda.Wealsoprovidetoolssuchasall-terrainvehiclesandtentstohelpmakesuretheprojectisabletoreachthemostremotecornersoftheregion.Rabiesinhumansanddomesticanimalshasnowbeenvirtuallyeliminatedfromthisareaandhumanhospitalizationsduetorabiddogbiteshavedecreased92percent.ELIAV:HCV[hepatitisCvirus]infectionisablood-bornedisease.Peoplebecomeinfectedwhenexposedtocontaminatedbloodproductsorcontaminatedsyringesorinjectionequipment.TheincidenceofHCVinfection(thenknownasnon-A/non-Bhepatitis)priorto1965waslow;however,therateincreasedsteadilyintothe1980s.In1988,HCVwasidentifiedandbloodsupplyscreeningforHCVbecameavailablein1992.Peoplegotinfectedandusuallydidn'tknowitbecausetheacuteinfectionistypicallyasymptomatic.Afterprolongedinfection,20to25years,orso,peoplewerepresentingwithadvancedliverdamage,whichcanleadtocirrhosisandeventuallyevenliverfailureorlivercancer.Ahugecohortofbabyboomersgotinfected,didn'tknowit,aregraduallygettingdiagnosedandfindingtheirdiseaseissoadvancedthattheyareapproachingacrisispoint.Theclockistickingonthisproblem.HbA1c,ameasureoftheaveragelevelofbloodsugaroverthepasttwotothreemonths,helpsyouandyourdoctorseehowwellyourdiabetestreatmentplanisworking.TherecommendedHbA1c,goalformanyadultswithtype2diabetesislessthan7%;however,thismayvarydependingontheindividual.Highbloodsugarlevelsovertimecanputpeoplewithdiabetesatriskofmanyserioushealthproblems,suchasheartdisease,stroke,kidneydisease,blindnessandnerveproblems.That’swhyitisimportantforpeoplelivingwithdiabetestoworkwiththeirdoctortosetindividualizedgoalsanddevelopapersonalizeddiabetesmanagementplantomanagetheABCsofdiabetes:AforHbA1c,BforbloodpressureandCforcholesterol.

  In1987,MSD’sthenCEODr.P.RoyVagelosannounced,inanunprecedentedactofglobalhealthcareleadership,thatMSDwoulddonateivermectin–asmuchasneededforaslongasneeded–withthegoaltohelpeliminateriverblindness.MSDrecognizedinordertoreachthisgoal,manyorganizationswithuniqueskillswouldneedtoworktogetherasateam.Asaresult,MSDcreatedtheMectizanDonationProgram(MDP).OperatingfromtheAtlanta-basedTaskForceforGlobalHealth,theMDPcoordinatesactivitiesbetweenMSD,WHO,theWorldBankandarangeofpublicandprivatestakeholders.In1998,MSDexpandeditscommitmentfromtheMectizanDonationProgramtoincludedonatingivermectinforanotherdisease,lymphaticfilariasis(LF),alsoknownaselephantiasis,inAfricancountriesandYemenwhereitco-existswithriverblindness.ForLF,ivermectinisadministeredwithalbendazole,adrugdonatedbyGSK.TheImpactofStigmatizationThesenorms,behaviors,andbeliefssurroundinghepatitisCinfectioncanleadtoalienationfromfamilyandfriends,aswellastodiscrimination(perceivedorreal)inhealthservicesandworkplaces.Indeed,manychronichepatitisCpatientsreportfeelingsofstigmatizationandsocialisolationfromtheirfriends,family,andcoworkers.WevetalkedtoHCVinfectedgrandmotherswhoseownchildrenwon’tallowthemtoplaywiththeirgrandchildrenbecausethey’reafraidofsomesortoftransmission,reportsMichaelNinburg,executivedirectoroftheHepatitisEducationProject,aSeattle-basedgroupfoundedin1993toprovideeducation,support,andadvocacyforthoselivingwithhepatitis.ArecentlydiagnosedpatientwhoworkswithMichael’sgroupechoedthissentiment.I'msuperoutgoing.ItalkabouteveryfeelingIhavetomyfriends,justaboutanybody,andmydiagnosiswassomethingIcouldnottalkabout,hesaid.IknewthatIhadtodosomethingaboutit,butIwasashamed.Overthepast125years,we’veseentheworldchangethroughthepowerofmedicineandinvention.Whileeachpivotalmilestonehasbeenunique,onethingtheyhaveincommonisthatwehaven’tdoneitalone.AtMSD,wehavealwaysbelievedthatgreatmedicalbreakthroughsrelyonteamwork–fromwithinandoutsideofMSD–andourhistoryhasprovenit.Weareproudtohaveworkedinpartnershipwithcompanies,academics,governments,patientorganizations,healthcareprofessionals,nongovernmentalorganizations(NGOs),multilateralorganizationsandothersintheprivatesector--tohelpimprovelivesaroundtheworldandcontinuetosolvesomeoftheworld’smostseriousillnesses.

  ELIAV:HCV[hepatitisCvirus]infectionisablood-bornedisease.Peoplebecomeinfectedwhenexposedtocontaminatedbloodproductsorcontaminatedsyringesorinjectionequipment.TheincidenceofHCVinfection(thenknownasnon-A/non-Bhepatitis)priorto1965waslow;however,therateincreasedsteadilyintothe1980s.In1988,HCVwasidentifiedandbloodsupplyscreeningforHCVbecameavailablein1992.Peoplegotinfectedandusuallydidn'tknowitbecausetheacuteinfectionistypicallyasymptomatic.Afterprolongedinfection,20to25years,orso,peoplewerepresentingwithadvancedliverdamage,whichcanleadtocirrhosisandeventuallyevenliverfailureorlivercancer.Ahugecohortofbabyboomersgotinfected,didn'tknowit,aregraduallygettingdiagnosedandfindingtheirdiseaseissoadvancedthattheyareapproachingacrisispoint.Theclockistickingonthisproblem.Antibioticshaverevolutionizedmedicineinmanyrespects,andcountlessliveshavebeensaved;theirdiscoverywasaturningpointinhumanhistory.Foralmostacentury,bacteria-fightingdrugsknownasantibioticshavehelpedtomanagemanyoftheharmfulbacteriathatcanmakeussick.Butinrecentdecades,theyhavebecomelesseffectiveagainstsometypesofbacteria.Currently,certainbacteriaarenowunbeatablewithtoday’smedicines.Unfortunately,newdrug-resistant“superbugs”haveemerged,whicharestrainsofbacteriathatareresistanttoseveraltypesofantibiotics.Infact,theWorldHealthOrganizationhasclassifiedthisas“aseriousthreat[that]isnolongerapredictionforthefuture,itishappeningrightnowineveryregionoftheworldandhasthepotentialtoaffectanyone,ofanyage,inanycountry.”TheMSDFellowshipforGlobalHealthisonewayMSDishelpinganswertheglobalhealthneedsoftheunderserved.MSDemployeeswhoparticipateintheprogramarecalledRichardT.ClarkFellows(RTCFellows)inhonorofretiredChairmanandCEORichardT.Clarkandhisphilosophyofpassion,purposeandcommitmenttocorporateresponsibility.Launchedin2012,theprogramoffersMSDemployeesopportunitiestosharetheirskillswithpeoplearoundtheworld.Asmanyas30Fellowsareselectedeachyear;theexpertiseoftheapplicantsismatchedtotheneedsofthepartnerorganizations.Duringthethree-monthassignments,theFellowsareembeddedwithinanon-profitorganizationinthefield.

责任编辑:www.oojbs.com_申慱娱乐试玩《Doctor-X》将出续集社友网:未经授权不得转载
关键词 >>

继续阅读

热新闻

热话题

热门推荐

关于我们 联系我们 版权声明 网站地图
百站百胜: 第九城市股价大涨后直线跳水跌幅超17% 德债收益率曲线逼近金融危机后最平专家料难以倒挂 少儿编程火爆引担忧:是否会成为中小学生新烦恼 警惕麻疹卷土重来 冰壶世锦赛中国女队一分憾负瑞士遗憾无缘四强 傅莹反驳美前财长:中国国际角色无须看美国脸色 猝不及防!主营“凉”了的盈方微要“戴帽” 邱淑贞女儿沈月上传时装周照片“刷屏” 欧盟要求评估5G安全风险但各国可采取单独措施 苹果最惨产品AirPower:技术总受阻商标被抢注 盈利增长高于预期,标普500是否会按历史模式触底? Grab总裁马明:共享经济在东南亚还有很大的发展空间 新浪观影团:《海市蜃楼》导演自曝灵感来自前任 余贺新:50蝶夺冠自谦“自己游得挺慢的” 红星美凯龙跌逾4%去年多赚近一成惟减派息 味千中国经营溢利降23%曾因投资百度外卖巨亏近5亿 海莉控诉粉丝强占有欲不理会贾斯汀歌迷负面评论 “铁饭碗”不好端也不好丢这5类人不得辞职 昆明一小区建好两年不交房开发商:卖亏了需业主补钱 重磅数据密集关键一周将临花旗建议押注波动性升温 落马的常德市委原副秘书长近千万财产来源不明 “吉戴恋”二胎落地,还原吉利戴姆勒合资smart始末 日奥委主席贿选被起诉几成定局炫耀奥运申办靠己 亚马逊、大众达成“工业云”合作将提高工厂效率 美国的“穷爸爸”和“富爸爸”是怎么赚钱和花钱的 苹果AirPower迟迟不见发布或因商标被抢注 罗志祥四月推出新专辑谈及专辑名直言:没想法啊 5G有哪些应用?小米、华为、中国移动博鳌热议物联网 “全国优秀县委书记”落马他是第3个 卡罗:不提过去不谈未来先把明天的三分拿到手 大和总研理事长中曾宏:亚洲仍将是世界经济增长引擎 不只是收益率曲线衰退风险已渗透到美国经济数据中 雷杰:呼吁新一届发审委大幅提高IPO过会率 2000元自费无痛针很“奢侈”:无痛分娩有望医保支持 国足VS乌兹别克首发:卡帅变换阵型谭龙何超登场 苹果昨晚啥都没发布但甩出了一堆收费项目 柯震东疑因复出无望患抑郁症,网友:自己毁的前途能怪谁? 富力飞翼领跑中超助攻榜赛后暴怒:像吃了苍蝇 范景翔现身公益自曝年少时被呼“蜡笔小新” 亚马逊联手美国国家科学基金会致力于AI公平性研究 周大福:郑嘉丽获委任为本公司独立非执行董事 上海“博学流浪汉”爆红网络:“我真不想红” 追平魔术师历史第一!可怕的是最佳新秀还不稳 扁家父子炸瑜扁:做過總統韓玩的把戲會看不懂? iQOO手机销售政策调整:每天十点限量发售 东方海外国际18年度纯利1.08亿美元同比减少21.… 马努的退场,不禁让人想到更为悲伤的问题 征服全美最强势老男人团估值百亿独角兽骗局被戳穿 阿森纳有意引进巴萨大将天价违约金高达5亿欧 影版《寻秦记》独缺嫪毒?江华:不知为什么要翻拍 不只是收益率曲线衰退风险已渗透到美国经济数据中 拉卡拉IPO迷雾:股权转让疑点多神秘PE屡\"高买低… VIC万字做空报告:特斯拉是升级版“庞氏骗局” 涉嫌组织卖淫敲诈勒索3起恶势力犯罪集团被宣判 “建墙”风波:美国防部拨款10亿美元建墙遭反对 韩国总统与民众互动随行警卫却从怀中掏出冲锋枪 中炬高新实控人变更为姚振华 10年期德债收益率自2016年以来首次低于日债! NASA好奇号探测器在火星上发现奇特的鹅卵石 华为高官:华为绝不会配合任何政府或情报部门 冠军赛收官:叶诗文徐嘉余揽三金孙杨傅园慧四金 华为去年研发费用破千亿元近十年研发投入超4800亿 英国“脱欧”要重来? 还记得叶诗文吗?如今强势回归的她不过才23岁 医院院长调任电视台长官场乱弹琴?湖南官方回应 不滿疑遭劈腿女子持刀將男友刺成重傷 大摩:支撑美元的三大干将全员叛变空军请有序入场 最想打的对手没进季后赛!里弗斯你黑谁呢? 德银:海底捞目标价升至21元维持持有评级 大S示爱木村拓哉被翻牌曝儿女的偶像是“他们” \"权游\"龙妈曝曾患重病:脑动脉瘤两次手术险丧命 英国今天不“脱欧”将再次对“脱欧”协议进行投票 爵士暴怒客场狂胜31分公牛无力仅一节就崩盘 2019的巴塞尔表展变样了?!听听中港台三地钟表专家怎… 叮当快药获6亿元融资招银国际、软银中国等投资 官宣!吉利戴姆勒组建合资公司国产smart品牌电动车 观赏一场没有“硝烟”的战争FE电动方程式三亚站 贾跃亭等到新金主?九城董事长朱骏赴美参观FF公司 才有溜背设计领克05谍照首次曝光 年轻人恋爱都不想谈,全球进入单身时代? 三年推四款曝斯柯达全新电动车计划 凌然:新能源新规不仅要说的严、更要做的严 响水化工厂爆炸致6人死亡董事长曾因污染环境罪获刑 村官回应被柔道冠军举报贪污:敢贪这钱早进监狱了 直击|苏宁进军大家电:发12款产品成立基金扶持企业 盧秀燕公佈百日政績綠營批割稻尾 前方-湖人球迷提前退场!五六百刀的票就不要了 Lyft的IPO为Uber奠定基础估值1200亿美元… 联讯策略:一季度完美收官二季度先上车再选座 55万亿美元债券市场陷入疯狂从投资级到高收益全涨 科研人员利用人工智能为癌症患者无创分级 快讯:长实集团实现净利401.17亿同比增加33% 旧金山考虑禁止亚马逊无现金商店 27罚14铁!辽宁罚球惨不忍睹多进1个早结束了 槟榔产业引发健康关注多个国家和地区对槟榔说\"不\" 交银国际:中银租赁目标价下调至65.86港元中性评级 华为高级副总裁:华为绝不会配合任何政府或情报部门 长飞光纤逆市涨逾4%惟本月累挫近22.54% 一图读懂:潘功胜“中国发展高层论坛”演讲要点 全球最大对冲基金桥水创始人看好中国投资机会 潘建伟获美国光学学会2019年度伍德奖 现任CEO斯隆突然辞职后富国银行寻找“救世主” 华北电力大学:免去戴松元可再生能源学院院长职务 博骏教育3月28日回购12万股耗资15万港币 特朗普下令撤回对朝鲜新制裁白宫:他喜欢金正恩 背靠背50+!22岁超新星比肩乔科艾史上最年轻 凤凰传媒:全资子公司间接投资蚂蚁金服723万元 钯金已经出现泡沫替代金属已经出现 福建三分王期待逆转上次辽闽对决曾打满5场 博鳌论坛上伊利发布“品质100计划”有何深意? 莫迪称印度反卫星试验成功外媒:或有助莫迪竞选 台湾马祖“蓝眼泪”季节已至首波小量现踪东莒(图) 四年来首次扭亏瑞信CEO薪水涨了30% 苹果最惨产品AirPower:技术总受阻商标被抢注 中超-4人齐开花王大雷献助攻鲁能4-2送天海3连败 129分18个三分34次助攻!这队居然进不去季后赛 娜比lisa时尚圈的甜美小公主又种草了哪些单品 大摩:申洲国际目标价降至110元维持增持评级 李克强会见萧万长一行 意大利人谈意拥抱一带一路:重回世界中心的一次努力 韩国2月工业产出大跌2.6%远逊于预期 胡锡进:今日台湾就是1949年被合围的北平! 密云丫髻山过火面积约500亩平谷区内仍在扑救 过年了!湖人时隔70天首次连胜!但还是联盟最菜 里拉遭去年崩盘以来最大跌幅土耳其对小摩展开调查 不能露腹肌?Justin给自己P魔性花纹笑翻网友 响水爆炸亲历者故事:废墟里表白妻子“我爱你” 林良铭:对手节奏快很不适应落后的时候没有放弃 在芯片领域中美厂商正进行另类竞赛 最高下调3.3万元雷克萨斯全系车型调价 特斯拉取消车辆年度维护计划 西班牙人队长:武磊让我们惊叹他还有进步的空间 小初满月啦!陈意涵手绘儿子同名啤酒照片与卡片 从赛车到民用版曝DaciaDusterEV谍照 四川:中小学幼儿园应建立陪餐制度校领导须参加 调查-你如何看国足再输泰国?卡帅要担多少责任? 除了养老金和健康俄罗斯老年人还面临这个担忧 天赋兑现!吹杨0.1秒准绝杀复刻詹皇霸气尽显 春假來襲,如何在大LA度過72小時! 苹果下代iPhone或许能够为其他设备无线充电 华为继续回应一切:源代码可查暂无上市计划 外媒提问时谬称蔡英文\"总统\"外交部发言人严词纠正 民代、機關首長優先公祭桃市民政局發文惹議 为什么美国永远不会有高铁?美媒:有四大原因 唯一利好!李磊经检检查无大碍病床上仍关注比赛 苹果下代iPhone或许能够为其他设备无线充电 首节丢40分快船仍翻盘豪取4连胜直逼西部第五 贾跃亭联手朱骏成立合资公司拟在中国设厂生产V9 4月1日起铁路货运降价降费预计每年让利约60亿元 体验波音新系统后,这家美国公司决定延长禁飞期限 美报告:击败中俄急需新战机B-21隐轰要288架 诺天王赛季新高狂虐勇士!黑八的仇告别战清了 避险情绪高涨黄金上破1320脱欧今晚有大消息 郑爽近照被说鼻子好吓人,网友:别再整了! 在美國辦理加拿大簽證指南(全新流程!19年3月重要更新… 名局!对轰7球!3-1变3-3不算完读秒世界波绝杀 双星闪耀全国游泳冠军赛孙杨王简嘉禾成双冠王 中升控股:2018年纯利升8.54%至36.37亿元 吹羊超乔丹库里独享历史第2还加冕1个历史第1 曼城强到变态!赢球只用半场利物浦咬碎牙也难追 州委常委被控巨额受贿:耍特权县委书记都被骂过 斯里兰卡国家电视台萨郎卡:要去提高内容质量 都挺好|巨婴男、直男癌、作妖父,这一家谁最让人失望… 发改委32次降价未果中国常用药价三年暴涨900%! 台大個人申請一階篩選102人通過五系篩選 尤文图斯官宣今夏来华热身7月24日PK国际米兰 綠營圍剿韓國瑜高市議員磨刀霍霍 大西雅圖地區3/23-24活動|啤酒節,色彩節,下… 每天订单降至不足200万单?顺风车限价合规待解 脱欧乱局之中不乏共识:英镑交易员希望首相梅留下来 价值投资失去活力,是暂时的还是永久的? 金卡戴珊坎耶携手助力公益筹款救助精神疾病患 《以团》决赛落幕双团出道赵品霖获人气团C位 俄军战舰在日本海举行反潜训练向假想敌发射鱼雷 直击|马云:在基础科学上希望有所作为 梅姨豁出去了!欧盟同意延期脱欧英镑黄金双双走低 发力下沉市场!手机淘宝将上线特卖区最快今天开启 乞讨长大的贪官最后贪掉68套房和30个车位 郭台铭亲自卖番石榴富士康迈出农业互联网第一步? 威少三双乔治31分海王25+12雷霆逆转胜步行者 韦世豪罚单太轻?能否杜绝是关键足球为何屡成热点 YG股东大会梁铉锡和弟弟连任成功胜利案无损地位 360鲁大师或于4月11日通过港交所聆讯5月中上旬上… 金博洋:秘诀是对自己更狠了未来目标再涨10分 亚洲最具竞争力的国家不是中国也不是日本是谁? 胡锡进批盐城爆炸政府舆论应对:总把正确性放前面 特朗普时代“新内战”阴霾笼罩美国? 美海軍爭預算使絕招一次拆解6艘巡洋艦 国君(香港):滨海投资目标价2.52港元维持买入评级 德银:下调华晨中国目标价至9元给予买入评级 北京尾号限行措施将第10次延期 郭京飞阐述心声告别苏明成:面对现实才有成长 开盘:欧洲数据疲软美股低开道指跌140点 响水爆炸后续:染料业恐短期震荡多企业子公司受波及